Other hearing loss

H8_OTHHEARINGLOSS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

12822

6. Filter based on genotype QC (FinnGen only)

12822

Control definitions (FinnGen only)

Control exclude
H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 115989 63773 51567
Only index persons 102436 57358 45078
Unadjusted period prevalence (%)
Whole population 1.65 1.83 1.44
Only index persons 1.94 2.11 1.72
Median age at first event (years)
Whole population 74.93 76.81 72.59
Only index persons 74.27 76.10 71.94

-FinnGen-

Key figures

All Female Male
Number of individuals 12822 6304 6518
Unadjusted period prevalence (%) 2.52 2.15 2.87
Median age at first event (years) 70.16 68.55 71.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
11378
Matched controls
111950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
DFF00
NOMESCO Finland
Pure tone audiometry
24.8
323.0
2757
1426
Z97.4
ICD-10 Finland
Presence of external hearing-aid
34.5
323.0
1817
613
H91.9
ICD-10 Finland
Hearing loss, unspecified
46.5
323.0
2805
781
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.8
323.0
3014
12960
H91.1
ICD-10 Finland
Presbycusis
72.5
323.0
5443
1396
DFF15
NOMESCO Finland
Speech audiometry
22.5
323.0
1201
584
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
185.4
323.0
1014
59
SPAT1043
SPAT
Audiometry
5.8
323.0
2068
4095
Z3229
NOMESCO Finland
Other healthcare associate professional
4.6
323.0
1630
3954
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
30.8
323.0
1147
405
H93.1
ICD-10 Finland
Tinnitus
12.0
323.0
925
816
DAX08
NOMESCO Finland
Fitting of hearing aid
35.3
323.0
1212
377
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
180.4
323.0
407
23
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.5
323.0
2148
5499
UDC00
NOMESCO Finland
Ear microscopy
10.6
323.0
1737
1870
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
30.7
323.0
2356
944
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
1006.8
323.0
3446
48
N07CA01
ATC
betahistine; oral
7.5
323.0
2030
3152
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
75.1
323.0
1425
213
R5140
NOMESCO Finland
Monitoring the use of the aid
4.0
323.0
1652
4560
H02
ICPC
Hearing complaint
6.5
323.0
2725
5191
Z01.1
ICD-10 Finland
Examination of ears and hearing
14.7
323.0
4014
4010
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
23.5
323.0
712
317
R5120
NOMESCO Finland
Preparation of an aid
21.4
323.0
1000
501
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
172.0
323.0
4907
491
H13
ICPC
Plugged feeling ear
2.6
296.5
2601
11389
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
41.8
279.9
355
86
H81.0
ICD-10 Finland
Ménière disease
9.9
265.6
558
579
R4135
NOMESCO Finland
Rehabilitation for hearing problems
36.4
250.2
327
91
3882A
ICD-9 Finland
Other disorders of ear, Sudden hearing loss, unspecified
+∞
248.3
239
*
H29
ICPC
Ear symptom/complaint other
3.1
236.1
1443
4960
H91.8
ICD-10 Finland
Other specified hearing loss
22.9
231.6
342
151
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
89.9
230.6
259
29
H84
ICPC
Presbyacusis
5.7
213.6
657
1196
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
46.6
212.8
264
57
H81
ICPC
Excessive ear wax
2.3
211.9
2256
10698
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
271.6
210.5
216
8
H02AB06
ATC
prednisolone; systemic
1.8
203.5
5438
37181
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.5
202.5
1058
3219
R42
ICD-10 Finland
Dizziness and giddiness
2.1
199.2
2916
15911
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.7
184.3
560
1002
N02BE01
ATC
paracetamol; systemic, rectal
2.0
181.3
9414
78921
A98
ICPC
Health maint/preventive medicine
2.0
160.3
9878
85325
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
+∞
155.6
150
*
TDA90
NOMESCO Finland
Removal wax from ear
11.9
155.0
294
248
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
19.6
152.2
236
121
H61.2
ICD-10 Finland
Impacted cerumen
3.1
136.5
813
2696
A02BC02
ATC
pantoprazole; systemic
1.6
126.3
6939
55088
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
8.5
121.5
277
329
J01DB01
ATC
cefalexin; oral
1.7
121.3
8340
69814
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
38.6
120.6
155
40
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
116.1
4332
30886
DFE00
NOMESCO Finland
Insertion of cochlear implant
+∞
110.9
107
*
R1260
NOMESCO Finland
Evaluation of communicative skills
5.5
109.3
342
631
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
9.6
109.0
230
239
H28
ICPC
Limited function/disability (H)
9.9
104.8
218
221
AA1AD
NOMESCO Finland
CT of head and brain
1.7
104.1
2838
18449
SPAT1310
SPAT
Counselling related to known health issue
1.6
103.6
3236
21837
DC1AD
NOMESCO Finland
Temporalbone CT
15.5
103.4
174
112
R01AD09
ATC
mometasone; nasal
1.6
102.6
3850
27234
DFF59
NOMESCO Finland
Other assessment of balance
11.7
102.0
194
165
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
97.2
4425
32678
H91.3
ICD-10 Finland
Deaf mutism, not elsewhere classified
941.0
96.5
95
*
SPAT1263
SPAT
Sampling
1.5
96.5
4291
31504
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
96.2
3678
26032
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.9
94.9
187
171
Z97.8
ICD-10 Finland
Presence of other specified devices
41.1
94.8
120
29
RK520
NOMESCO Finland
NA
21.1
94.3
142
67
SPAT1301
SPAT
No procedures
1.6
94.2
3443
24065
J01CA04
ATC
amoxicillin; systemic
1.5
90.8
7837
66279
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
90.5
2177
13553
SPAT1325
SPAT
Vaccination
1.5
90.5
3878
28099
R5599
NOMESCO Finland
Other rehabilitation service
3.8
86.3
383
1006
ZXA10
NOMESCO Finland
Bilateral
1.7
86.2
2189
13824
SPAT1312
SPAT
General health counselling
1.6
84.4
2995
20657
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
81.5
4251
31968
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
80.9
4036
30049
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
80.2
2360
15482
H92.0
ICD-10 Finland
Otalgia
3.3
79.6
423
1284
M79.6
ICD-10 Finland
Pain in limb
1.5
78.5
3401
24500
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
29.5
78.5
107
36
H80.9
ICD-10 Finland
Otosclerosis, unspecified
12.9
77.2
140
108
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
77.1
2934
20497
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
75.2
4645
35984
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.0
73.0
1016
5215
SPAT1041
SPAT
Comprehensive hearing test
7.1
72.8
185
261
M54.5
ICD-10 Finland
Low back pain
1.5
72.1
2916
20594
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
71.9
2822
19792
S18
ICPC
Laceration/cut
1.5
71.8
4244
32488
DFX00
NOMESCO Finland
Connecting cochlear implant
+∞
71.5
69
*
SPAT1260
SPAT
Consultation of another employee
1.7
70.3
1819
11467
H81.3
ICD-10 Finland
Other peripheral vertigo
3.4
70.2
358
1053
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
10.7
70.2
139
129
R06.0
ICD-10 Finland
Dyspnoea
1.5
69.7
2698
18837
SPAT1153
SPAT
Removal of sutures
1.5
69.1
3229
23503
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
68.5
2574
17833
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
68.4
4279
33032
RK320
NOMESCO Finland
NA
7.3
68.2
170
233
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
67.9
4418
34343
WX110
NOMESCO Finland
Local anesthesy
1.4
67.8
6119
50551
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
66.4
2629
18414
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
65.1
5905
48665
R01AD12
ATC
fluticasone furoate; nasal
1.6
64.9
2137
14318
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
33.7
64.6
85
25
DFF16
NOMESCO Finland
Speech-in-noise audiometry
318.7
64.1
65
*
R05
ICPC
Cough
1.6
63.3
2014
13370
SPAT1053
SPAT
Memory test
1.6
63.1
1939
12755
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
5.1
62.2
205
403
R51.80
ICD-10 Finland
Headache
1.8
62.0
1194
6864
D33.30
ICD-10 Finland
Acoustic neuroma
14.6
61.9
106
72
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
61.7
3220
23851
G04CA02
ATC
tamsulosin; oral
1.5
61.1
2804
20215
J01AA02
ATC
doxycycline; systemic
1.4
60.6
7888
68866
H91.0
ICD-10 Finland
Ototoxic hearing loss
581.6
59.4
59
*
N17
ICPC
Vertigo/dizziness
1.8
59.1
1177
6835
M03BX02
ATC
tizanidine; oral
1.4
59.1
5193
42249
RK110
NOMESCO Finland
NA
6.9
58.9
152
220
M25.5
ICD-10 Finland
Pain in joint
1.5
58.7
2353
16457
RK420
NOMESCO Finland
NA
105.5
58.4
64
6
M01AH05
ATC
etoricoxib; oral
1.4
58.4
5021
40669
-1
NOMESCO Finland
NA
1.5
58.3
2625
18819
P20
ICPC
Memory disturbance
1.6
58.0
1566
9936
3897A
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]
+∞
58.0
56
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
57.8
3093
22964
DFX03
NOMESCO Finland
Review, maintenance and user education for hearing aid
40.1
57.7
73
18
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
57.5
1702
11061
R03AC02
ATC
salbutamol; inhalant
1.4
57.5
4777
38426
H04
ICPC
Ear discharge
2.9
57.2
363
1245
A02BC03
ATC
lansoprazole; oral
1.4
57.2
3026
22407
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
56.8
1072
6114
J01FA10
ATC
azithromycin; systemic
1.4
56.4
4736
38121
A02BC05
ATC
esomeprazole; systemic
1.4
55.5
3854
29984
H02AB04
ATC
methylprednisolone; systemic
1.6
55.3
1467
9253
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
54.6
3164
23792
SPAT1097
SPAT
Recording of ECG
1.6
54.2
1591
10303
G44.2
ICD-10 Finland
Tension-type headache
1.8
53.6
1062
6149
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
52.4
3656
28390
H01
ICPC
Ear pain/earache
1.9
52.1
817
4365
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
52.0
3240
24645
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.9
52.0
334
1158
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
+∞
51.8
50
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
51.6
1651
10912
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.5
51.2
424
1705
H26.4
ICD-10 Finland
After-cataract
1.7
51.1
1179
7141
R01AD08
ATC
fluticasone; nasal
1.5
51.0
2268
16146
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
50.8
6580
56407
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
50.8
5110
42101
H83.3
ICD-10 Finland
Noise effects on inner ear
6.8
50.4
131
192
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.8
50.3
173
357
XKD00
NOMESCO Finland
Uroflowmetry
1.5
49.9
1847
12625
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
49.2
507
2277
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
49.2
3384
26145
L17
ICPC
Foot/toe symptom/complaint
1.5
48.8
2348
16964
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
47.6
1222
7618
L08
ICPC
Shoulder symptom/complaint
1.5
47.4
1684
11391
UKC02
NOMESCO Finland
Cystoscopy
1.5
46.6
1850
12825
C07AB07
ATC
bisoprolol; oral
1.3
46.6
5388
45120
L03
ICPC
Low back symptom/complaint
1.5
46.6
2059
14604
DDA00
NOMESCO Finland
Stapedotomy
11.3
46.1
88
77
A28
ICPC
Limited function/disability NOS
1.5
45.7
1906
13342
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
45.7
1543
10305
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
45.7
8453
75926
R53
ICD-10 Finland
Malaise and fatigue
1.5
44.9
2108
15115
TDA90
SPAT
NA
3.1
44.8
259
837
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
44.4
2958
22635
ZXA00
NOMESCO Finland
Right side
1.4
44.2
2880
21948
H60.3
ICD-10 Finland
Other infective otitis externa
3.4
43.9
218
630
R02
ICPC
Shortness of breath/dyspnoea
1.6
43.9
1192
7537
SPAT1262
SPAT
Handing over of treatment supplies
1.5
43.6
1845
12943
R05
ICD-10 Finland
Cough
1.5
43.2
1727
11967
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.8
42.9
147
303
H91
ICD-10 Finland
Other hearing loss
6.2
42.7
118
189
N06AX11
ATC
mirtazapine; oral
1.4
42.3
2864
21941
M01AX05
ATC
glucosamine; oral
1.4
41.9
2197
16072
ZXA05
NOMESCO Finland
Left side
1.4
41.9
2711
20601
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
41.7
560
2819
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
41.5
1527
10383
H71
ICD-10 Finland
Cholesteatoma of middle ear
5.5
41.2
126
229
G47.3
ICD-10 Finland
Sleep apnoea
1.5
41.1
1661
11520
C10AA01
ATC
simvastatin; oral
1.3
41.0
5045
42305
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
40.8
2023
14630
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
40.8
1633
11307
RK120
NOMESCO Finland
NA
12.9
40.7
73
56
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
40.5
1699
11880
38920
ICD-8 Finland
Other deafness, Deafness, one ear
+∞
40.4
39
*
N03AX12
ATC
gabapentin; oral
1.5
40.2
1367
9121
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
40.0
4376
36046
J01MA02
ATC
ciprofloxacin; systemic
1.3
39.8
3951
32079
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
39.8
2845
21948
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
39.5
383
1672
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
39.4
2843
21958
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
32.1
39.3
52
16
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
38.7
4177
34284
A02BC01
ATC
omeprazole; systemic
1.4
38.7
2833
21922
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.7
38.6
113
195
RK530
NOMESCO Finland
NA
197.4
38.6
40
*
R01AD01
ATC
beclometasone; nasal
1.6
38.6
1244
8195
G04BD12
ATC
mirabegron; oral
1.6
38.5
1043
6577
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
38.5
1324
8854
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
38.0
632
3441
L01
ICPC
Neck symptom/complaint
1.6
37.8
1080
6904
H66.9
ICD-10 Finland
Otitis media, unspecified
2.3
37.7
355
1530
-44
ICPC
Preventive immunization/medic
1.7
37.6
910
5563
ZXC50
NOMESCO Finland
Cryotherapy
2.2
37.6
381
1698
K02.1
ICD-10 Finland
Caries of dentine
1.3
37.4
4360
36122
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
37.3
3427
27436
N03AX16
ATC
pregabalin; oral
1.4
36.8
2114
15677
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
36.7
3764
30600
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.0
36.6
490
2462
Z71.8
ICD-10 Finland
Other specified counselling
1.4
36.6
1947
14234
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
36.2
592
3202
UJF32
NOMESCO Finland
Coloscopy
1.4
35.9
2532
19426
R06AE07
ATC
cetirizine; oral
1.3
35.9
3551
28700
R74
ICPC
Upper respiratory infection acute
1.4
35.8
1784
12875
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
35.8
2830
22114
M01AB05
ATC
diclofenac; systemic, rectal
1.3
35.6
6022
52291
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
35.5
1451
10066
38998
ICD-8 Finland
Other deafness, Alia definita
+∞
35.2
34
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
35.2
1472
10256
Z00.0
ICD-10 Finland
General medical examination
1.4
35.0
1674
11985
L15
ICPC
Knee symptom/complaint
1.4
34.7
1791
13006
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.9
34.6
146
370
H03
ICPC
Tinnitus, ringing/buzzing ear
3.4
34.4
171
497
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
34.3
4329
36120
38999
ICD-8 Finland
Other deafness, Impairment of hearing, one or both ears
+∞
34.2
33
*
D07AC01
ATC
betamethasone; topical
1.3
33.9
3099
24712
SPAT1304
SPAT
Counselling and guidance related to ageing
1.6
33.8
836
5140
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
33.7
2905
22959
L12
ICPC
Hand/finger symptom/complaint
1.5
33.7
1140
7580
E0000UV
ATC
NA
1.3
33.6
3451
27976
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
33.6
2489
19220
M02AA07
ATC
piroxicam; topical
1.3
33.3
3641
29760
Z25.1
ICD-10 Finland
Need for immunization against influenza
1.9
33.1
516
2745
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
33.1
3377
27334
L13
ICPC
Hip symptom/complaint
1.5
33.1
1466
10324
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
33.1
511
2708
L57.0
ICD-10 Finland
Actinic keratosis
1.5
32.9
1114
7403
38699
ICD-8 Finland
NA
6.9
32.5
82
117
R21
ICPC
Throat symptom/complaint
1.5
32.3
1214
8260
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
31.8
1304
9035
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
31.4
1589
11475
H60.8
ICD-10 Finland
Other otitis externa
2.7
31.4
222
821
U04
ICPC
Incontinence urine
1.9
31.3
504
2711
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
31.2
617
3552
N02AX02
ATC
tramadol; systemic, rectal
1.3
31.1
4089
34161
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
31.1
623
3599
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.7
31.1
678
4019
IHA10
NOMESCO Finland
Structured mapping of problematic alcohol use
6.8
30.9
79
115
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
30.7
602
3454
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
30.3
2456
19176
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
30.3
1360
9595
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
30.2
2718
21547
D82
ICPC
Teeth/gum disease
1.3
30.1
2391
18612
A04
ICPC
Weakness/tiredness general
1.5
30.1
1223
8456
38900
ICD-8 Finland
Other deafness, Deafness, both ears
+∞
30.0
29
*
C10AA05
ATC
atorvastatin; oral
1.3
30.0
3949
32950
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
13.5
29.9
52
38
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
29.8
1313
9223
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
29.5
746
4608
U02
ICPC
Urinary frequency/urgency
1.5
29.5
1136
7763
G04CA01
ATC
alfuzosin; oral
1.5
29.3
1176
8105
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
29.1
931
6098
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
29.1
345
1650
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
29.1
1765
13151
3899X
ICD-9 Finland
Deafness, Unspecified deafness
+∞
29.0
28
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
28.9
906
5908
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
28.8
944
6219
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
28.8
1439
10357
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
28.8
2088
16013
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
28.7
960
6357
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
28.7
5946
52274
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.5
28.7
973
6464
SPAT1058
SPAT
PEF monitoring instruction
1.6
28.7
702
4299
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
28.6
540
3063
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
28.5
1343
9558
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
28.4
1207
8416
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
28.2
1045
7080
KMAK
NOMESCO Finland
NA
1.3
28.2
3983
33451
N30.0
ICD-10 Finland
Acute cystitis
1.4
27.9
1294
9181
B01AC04
ATC
clopidogrel; oral
1.4
27.8
1758
13176
L28
ICPC
Limited function/disability (L)
1.4
27.8
1682
12517
-69
ICPC
Other reason for encounter NEC
1.9
27.6
407
2125
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.6
27.5
669
4093
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
6.9
27.4
69
99
H65.2
ICD-10 Finland
Chronic serous otitis media
4.2
27.3
106
251
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
27.0
764
4856
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
27.0
1582
11702
R39.1
ICD-10 Finland
Other difficulties with micturition
2.1
26.9
303
1421
C10AA07
ATC
rosuvastatin; oral
1.3
26.8
2169
16887
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
26.7
2403
18995
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
26.7
1323
9495
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
26.7
743
4703
SPAT1211
SPAT
Application of soft bandage
1.6
26.6
819
5312
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
26.6
1747
13168
S82
ICPC
Naevus/mole
1.5
26.6
963
6486
-31
ICPC
Medical examin/health eval partial
1.6
26.5
649
3976
R55
ICD-10 Finland
Syncope and collapse
1.5
26.2
1125
7854
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
26.0
1638
12255
N05CF01
ATC
zopiclone; oral
1.3
25.9
3316
27437
Z45.3
ICD-10 Finland
Adjustment and management of implanted hearing device
+∞
25.9
25
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.1
25.9
291
1363
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
25.8
2784
22542
S29
ICPC
Skin symptom/complaint other
1.4
25.7
1478
10893
SPAT1131
SPAT
Colonoscopy
2.0
25.7
329
1629
R06AX27
ATC
desloratadine; oral
1.4
25.6
1750
13270
G04BD08
ATC
solifenacin; oral
1.6
25.5
679
4250
A02BA02
ATC
ranitidine; systemic
1.3
25.5
2015
15620
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
25.5
1988
15381
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
25.4
1937
14930
M79.1
ICD-10 Finland
Myalgia
1.5
25.3
935
6329
C03CA01
ATC
furosemide; systemic
1.3
25.2
3711
31203
R13
ICD-10 Finland
Dysphagia
1.7
25.0
587
3551
H81.2
ICD-10 Finland
Vestibular neuronitis
2.6
25.0
182
686
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
25.0
2310
18310
K30
ICD-10 Finland
Functional dyspepsia
1.5
24.9
820
5403
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
24.9
998
6868
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
24.8
490
2819
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
24.8
2317
18385
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.6
24.8
762
4941
J01DA01
ATC
[U] cefalexin; systemic
1.2
24.8
5943
52695
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
24.7
890
5987
ZXC15
NOMESCO Finland
Use of photodynamic technique
2.7
24.5
176
658
M01AE02
ATC
naproxen; oral, rectal
1.2
24.5
4774
41376
C01DA14
ATC
isosorbide mononitrate; oral
1.3
24.5
2071
16199
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
24.5
2713
22014
DC1AI
NOMESCO Finland
Cone beam CT of ear
246.6
24.5
25
*
J05AB01
ATC
aciclovir; systemic
1.3
24.4
1713
13030
RK290
NOMESCO Finland
NA
8.9
24.3
52
58
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
24.3
1381
10148
M01AC06
ATC
meloxicam; systemic, rectal
1.3
24.2
3158
26142
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
24.2
2004
15627
Z01.2
ICD-10 Finland
Dental examination
1.3
24.2
2966
24369
M02AA10
ATC
ketoprofen; topical
1.4
24.2
1411
10412
207
Kela drug reimbursment
Chronic arrhythmias
1.3
24.1
1665
12628
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
24.1
3676
30996
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
23.7
860
5790
H93.2
ICD-10 Finland
Other abnormal auditory perceptions
5.6
23.5
69
122
R06.5
ICD-10 Finland
Mouth breathing
1.6
23.3
596
3692
H25.8
ICD-10 Finland
Other senile cataract
1.4
23.2
1213
8779
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
23.2
1337
9844
J02AC01
ATC
fluconazole; systemic
1.3
23.1
2930
24139
S01BC05
ATC
ketorolac; ophthalmic
1.7
23.0
490
2886
R04.0
ICD-10 Finland
Epistaxis
1.5
23.0
722
4706
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
1.5
23.0
825
5543
J01EA01
ATC
trimethoprim; systemic
1.3
22.9
2425
19541
SPAT1044
SPAT
Tympanometry
2.7
22.9
157
572
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
22.8
1331
9817
C08CA01
ATC
amlodipine; oral
1.2
22.8
3772
32038
D07AC13
ATC
mometasone; topical
1.3
22.7
2446
19744
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
8.1
22.7
51
62
B01AF02
ATC
apixaban; oral
1.4
22.5
1028
7255
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
22.4
880
6024
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
22.4
2329
18712
M48.0
ICD-10 Finland
Spinal stenosis
1.4
22.3
1217
8869
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
22.3
1917
15012
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
22.2
1587
12089
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.3
22.2
2557
20807
XF404
NOMESCO Finland
Ambulatory ECG
1.5
22.2
885
6081
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
22.1
1186
8618
F29
ICPC
Eye symptom/complaint other
1.6
22.0
618
3918
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
22.0
3006
24964
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
21.8
1925
15120
P06
ICPC
Sleep disturbance
1.6
21.8
662
4280
J01FA09
ATC
clarithromycin; systemic
1.3
21.8
2379
19224
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
21.7
21
*
38801
ICD-8 Finland
Deaf mutism, Congenita
+∞
21.7
21
*
Z00.8
ICD-10 Finland
Other general examinations
1.6
21.7
566
3523
N01
ICPC
Headache
1.6
21.6
589
3707
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
6.7
21.6
55
81
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.0
21.6
277
1371
S21
ICPC
Skin texture symptom/complaint
1.4
21.5
1069
7661
G04CB02
ATC
dutasteride; oral
1.5
21.3
663
4312
SPAT1254
SPAT
Administration of medicine
1.3
21.1
1412
10638
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
21.1
1892
14891
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
21.0
1161
8476
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
21.0
1399
10536
A03
ICPC
Fever
1.4
21.0
977
6920
A97
ICPC
No disease
1.4
20.9
1239
9160
M01AX17
ATC
nimesulide; oral
1.3
20.8
2284
18448
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.6
20.7
548
3425
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
20.7
1776
13885
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
3.6
20.7
93
253
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
20.5
1371
10326
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.5
20.5
780
5304
C05AA08
ATC
fluocortolone; rectal, topical
1.4
20.5
1206
8903
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
11.4
20.4
38
33
WZC30
NOMESCO Finland
Teaching
1.4
20.3
1087
7892
A06AC51
ATC
ispaghula, combinations; systemic
1.7
20.2
422
2472
L14
ICPC
Leg/thigh symptom/complaint
1.5
20.2
630
4102
S06.0
ICD-10 Finland
Concussion
1.5
20.1
839
5815
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
3.7
20.0
87
230
R07.0
ICD-10 Finland
Pain in throat
1.8
19.9
374
2122
R60.0
ICD-10 Finland
Localized oedema
1.4
19.9
1059
7679
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.0
19.9
269
1363
R35
ICD-10 Finland
Polyuria
1.6
19.9
582
3728
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
19.8
831
5762
RK220
NOMESCO Finland
NA
6.8
19.8
50
73
DCA30
NOMESCO Finland
Exploration of middle ear
72.4
19.5
22
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
19.5
1028
7439
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
19.5
835
5812
I49.5
ICD-10 Finland
Sick sinus syndrome
1.7
19.5
457
2766
A11
ICPC
Chest pain NOS
1.5
19.4
648
4284
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.6
19.3
485
2987
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
3.5
19.3
90
253
D06
ICPC
Abdominal pain localized other
1.6
19.3
577
3721
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
19.2
1260
9454
SPAT1229
SPAT
Assessment of need for aid
1.5
19.2
796
5508
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
19.2
547
3485
SPAT1216
SPAT
Assessment of functional ability
1.3
19.2
1535
11874
ZXE00
NOMESCO Finland
One hour or less
1.2
19.0
3606
30911
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
19.0
2649
21982
A06AD11
ATC
lactulose; oral
1.3
19.0
1643
12848
J01FA06
ATC
roxithromycin; oral
1.2
19.0
3555
30440
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
18.9
2079
16769
AN1
HP
Coronary angiography
1.3
18.9
1290
9744
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
18.7
3574
30654
B01AB05
ATC
enoxaparin; parenteral
1.2
18.5
2815
23569
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
18.5
837
5892
C09CA01
ATC
losartan; oral
1.3
18.5
2271
18563
H65.0
ICD-10 Finland
Acute serous otitis media
3.1
18.4
102
326
R31
ICD-10 Finland
Unspecified haematuria
1.4
18.4
1019
7440
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
18.3
498
3134
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
6.9
18.2
45
64
R11
ICD-10 Finland
Nausea and vomiting
1.5
18.1
677
4587
H83.1
ICD-10 Finland
Labyrinthine fistula
21.4
18.0
26
12
R52.9
ICD-10 Finland
Pain, unspecified
1.5
18.0
645
4332
SPAT1252
SPAT
Overall medication plan or its review
1.5
17.9
688
4687
L16
ICPC
Ankle symptom/complaint
1.5
17.9
740
5113
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.1
17.9
200
939
R15
ICD-10 Finland
Faecal incontinence
2.0
17.9
242
1227
K80
ICPC
Cardiac arrhythmia NOS
1.5
17.9
613
4078
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
14.1
17.9
30
21
R03DC03
ATC
montelukast; oral
1.4
17.8
1106
8224
H02.3
ICD-10 Finland
Blepharochalasis
1.5
17.8
541
3500
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
17.8
743
5146
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.6
17.8
486
3061
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
4.5
17.7
63
139
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
17.7
951
6901
P01AB01
ATC
metronidazole; oral, rectal
1.2
17.7
3185
27116
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
17.7
731
5057
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.5
17.6
685
4680
J05AB11
ATC
valaciclovir; oral
1.4
17.5
1004
7369
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
17.5
793
5583
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
17.5
1698
13473
R03BA05
ATC
fluticasone; inhalant
1.3
17.4
1399
10815
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.6
17.4
485
3076
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
17.3
1743
13896
C09CA06
ATC
candesartan; oral
1.3
17.2
1794
14359
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
17.1
1806
14476
H70.1
ICD-10 Finland
Chronic mastoiditis
7.2
17.1
41
56
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.5
17.1
543
3547
HAHOM
NOMESCO Finland
NA
3.1
17.1
96
311
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
2.8
17.1
112
401
XF402
NOMESCO Finland
ECG with work load test
1.4
17.1
998
7350
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
17.0
645
4379
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
17.0
721
5009
R5430
NOMESCO Finland
Interpreter's services
7.7
17.0
39
50
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.6
16.9
503
3236
D11
ICPC
Diarrhoea
1.4
16.9
706
4893
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.3
16.8
1284
9856
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
16.8
923
6728
T16
ICD-10 Finland
Foreign body in ear
3.6
16.7
75
205
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
25.2
16.7
23
9
H80
ICD-10 Finland
Otosclerosis
19.0
16.7
25
13
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
16.7
950
6966
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
16.6
1111
8356
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
16.6
1426
11123
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
16.6
974
7177
R51
ICD-10 Finland
Headache
1.7
16.6
314
1786
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
16.6
1032
7677
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
16.5
2648
22245
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
16.5
2825
23900
XCH00
NOMESCO Finland
Eye pressure measurement
1.7
16.4
366
2188
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.0
16.3
207
1026
RK510
NOMESCO Finland
NA
7.5
16.3
38
50
C09AA05
ATC
ramipril; oral
1.2
16.3
2619
22002
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
16.3
539
3555
R50.9
ICD-10 Finland
Fever, unspecified
1.3
16.3
1153
8748
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
16.2
241
1265
WX002
NOMESCO Finland
Sedation and analgesia
1.3
16.2
1777
14302
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
16.2
623
4244
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.7
16.2
347
2050
D01
ICPC
Abdominal pain/cramps general
1.4
16.2
718
5032
N06AX21
ATC
duloxetine; oral
1.4
16.2
711
4977
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
16.1
2237
18498
-51
ICPC
I&d/flush/aspiration
2.5
16.1
127
505
R09
ICPC
Sinus symptom/complaint
1.6
16.1
438
2759
R00.2
ICD-10 Finland
Palpitations
1.6
16.0
467
2993
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
16.0
424
2652
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
15.9
636
4369
A02BC04
ATC
rabeprazole; oral
1.5
15.9
571
3839
H03AA01
ATC
levothyroxine sodium; systemic
1.2
15.8
1949
15898
H80.8
ICD-10 Finland
Other otosclerosis
11.4
15.8
29
25
SPAT1377
SPAT
Polysomnography
1.9
15.6
224
1161
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.9
15.6
224
1163
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
15.6
584
3958
J34.2
ICD-10 Finland
Deviated nasal septum
1.7
15.6
323
1892
ZXD05
NOMESCO Finland
Urgent procedure
1.2
15.6
2807
23836
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
15.6
650
4504
A01
ICPC
Pain general/multiple sites
1.5
15.6
623
4279
DFF50
NOMESCO Finland
Electronystagmography
10.2
15.5
30
29
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
15.4
3344
28904
S06
ICPC
Rash localized
1.6
15.4
444
2840
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.3
15.4
1293
10052
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
15.3
342
2049
N05BA04
ATC
oxazepam; oral
1.2
15.3
2151
17808
R03BA08
ATC
ciclesonide; inhalant
1.5
15.2
547
3678
H90
ICD-10 Finland
Conductive and sensorineural hearing loss
9.3
15.2
31
33
S22.3
ICD-10 Finland
Fracture of rib
1.5
15.2
538
3606
R07.3
ICD-10 Finland
Other chest pain
1.4
15.2
767
5509
ZYC01
SPAT
NA
1.6
15.1
350
2114
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
15.1
790
5708
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.5
15.1
474
3091
H43
ICPC
Ear, Other diagnostic procedure
6.9
15.1
37
53
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.4
15.1
660
4615
I95.1
ICD-10 Finland
Orthostatic hypotension
1.6
15.0
364
2226
R05FB02
ATC
cough suppressants and expectorants
1.2
15.0
3575
31140
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
1.6
15.0
440
2827
J01CA08
ATC
pivmecillinam; oral
1.2
14.9
3240
27992
C08CA13
ATC
lercanidipine; oral
1.3
14.8
1261
9814
H01.0
ICD-10 Finland
Blepharitis
1.6
14.8
360
2204
4133
FHL
Stapedectomy sampling
5.5
14.8
43
77
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.3
14.8
962
7205
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.4
14.8
892
6599
OAB42
SPAT
NA
1.7
14.8
320
1901
WX320
NOMESCO Finland
Spinalanesthesy
1.2
14.7
1982
16317
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
14.6
332
1995
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
3.1
14.6
79
251
M54.3
ICD-10 Finland
Sciatica
1.6
14.6
429
2754
RL210
NOMESCO Finland
NA
4.8
14.6
48
99
M54
ICD-10 Finland
Dorsalgia
1.4
14.6
769
5561
J37.0
ICD-10 Finland
Chronic laryngitis
1.9
14.5
225
1201
K85
ICPC
Elevated blood pressure
1.3
14.5
1371
10818
XCK00
NOMESCO Finland
Perimetry
1.4
14.5
615
4273
K78
ICPC
Atrial fibrillation/flutter
1.4
14.5
833
6114
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
8.5
14.5
31
36
DCD00
NOMESCO Finland
Myringoplasty
4.5
14.5
51
113
ZXH06
SPAT
NA
2.0
14.5
181
894
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.5
14.5
529
3569
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
3.7
14.4
63
170
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.5
14.4
494
3289
R96
ICPC
Asthma
1.4
14.3
649
4567
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
14.3
764
5539
XQ800
NOMESCO Finland
Prick test
1.6
14.3
405
2579
J01FF01
ATC
clindamycin; systemic
1.2
14.2
2212
18484
H51
ICPC
Ear, I&d/flush/aspiration
2.4
14.2
122
510
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.8
14.2
234
1277
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.9
14.2
192
979
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
14.2
1097
8427
M54.2
ICD-10 Finland
Cervicalgia
1.5
14.2
459
3017
H60
ICD-10 Finland
Otitis externa
1.7
14.1
263
1493
M01AH02
ATC
rofecoxib; oral
1.3
14.1
1198
9321
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
14.1
702
5028
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.5
14.1
536
3644
S70.0
ICD-10 Finland
Contusion of hip
1.6
14.1
338
2065
L04
ICPC
Chest symptom/complaint
1.5
14.1
423
2733
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
4.7
14.0
47
99
D12
ICPC
Constipation
1.7
14.0
304
1806
WX723
NOMESCO Finland
CPAP therapy
1.8
14.0
219
1175
D01BA02
ATC
terbinafine; oral; topical
1.2
14.0
2054
17058
S01EE01
ATC
latanoprost; ophthalmic
1.4
14.0
647
4573
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.2
14.0
71
216
D01AE16
ATC
amorolfine; topical
1.3
14.0
988
7488
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
14.0
560
3851
X58
ICD-10 Finland
Exposure to other specified factors
1.3
14.0
919
6890
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
13.9
303
1801
U01
ICPC
Dysuria/painful urination
1.5
13.9
535
3645
S22
ICPC
Nail symptom/complaint
1.5
13.9
456
3007
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
13.9
355
2205
A03FA02
ATC
cisapride; oral, rectal
1.4
13.8
754
5483
R32
ICD-10 Finland
Unspecified urinary incontinence
1.8
13.8
244
1363
N05AB04
ATC
prochlorperazine; systemic, rectal
1.8
13.8
242
1348
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
13.8
541
3701
F05
ICPC
Visual disturbance other
1.9
13.8
209
1109
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
13.8
444
2914
R06AE09
ATC
levocetirizine; oral
1.3
13.7
902
6764
DE2CF
NOMESCO Finland
Acoustic channel extensive MRI examination with median intensity magnet
52.5
13.7
16
*
H61.8
ICD-10 Finland
Other specified disorders of external ear
2.7
13.6
89
320
R29
ICPC
Respiratory symptom/complaint other
1.5
13.6
428
2795
RK322
NOMESCO Finland
NA
10.2
13.5
26
25
WZA90
NOMESCO Finland
Other doctors statement
1.2
13.5
1605
13018
S04
ICPC
Lump/swelling localized
1.4
13.5
659
4702
H27
ICPC
Fear of ear disease
2.8
13.5
84
293
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
13.5
535
3671
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
13.5
545
3755
RK111
NOMESCO Finland
NA
+∞
13.5
13
*
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
+∞
13.5
13
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
13.4
790
5820
K08.80
ICD-10 Finland
Toothache NOS
1.5
13.4
429
2810
H74.1
ICD-10 Finland
Adhesive middle ear disease
6.8
13.4
33
48
T90
ICPC
Diabetes non-insulin dependent
1.2
13.4
2068
17257
H69.0
ICD-10 Finland
Patulous Eustachian tube
4.3
13.4
48
109
D02
ICPC
Abdominal pain epigastric
1.6
13.3
385
2464
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
13.2
1715
14048
KED22
NOMESCO Finland
Transurethral resection of prostate
1.4
13.2
626
4443
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.8
13.2
225
1243
W19
ICD-10 Finland
Unspecified fall
1.4
13.2
791
5846
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.5
13.1
456
3045
N04BC05
ATC
pramipexole; oral
1.4
13.1
599
4221
A01AB09
ATC
miconazole; local oral
1.4
13.1
772
5691
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
1.6
13.0
327
2019
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
13.0
1799
14830
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
13.0
423
2785
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.7
13.0
275
1622
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.5
13.0
449
2996
UDM02
NOMESCO Finland
Sinoscopy
2.1
13.0
145
687
WX720
NOMESCO Finland
Own respiration
1.7
12.9
273
1612
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
6.7
12.9
32
47
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
12.9
585
4118
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.6
12.9
370
2368
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.4
12.9
701
5099
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.6
12.9
301
1829
B01AF01
ATC
rivaroxaban; oral
1.3
12.8
1049
8117
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
12.8
490
3339
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.2
12.8
1544
12546
N05CF02
ATC
zolpidem; oral
1.3
12.7
1244
9853
H71
ICPC
Acute otitis media/myringitis
3.1
12.7
69
221
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
1.8
12.7
213
1170
P01
ICPC
Feeling anxious/nervous/tense
1.5
12.7
431
2865
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
12.6
832
6238
S16
ICPC
Bruise/contusion
1.7
12.6
258
1509
J30.0
ICD-10 Finland
Vasomotor rhinitis
1.9
12.6
175
901
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.7
12.6
243
1397
VALMI
NOMESCO Finland
NA
1.2
12.6
1610
13165
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.4
12.5
545
3808
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.2
12.5
129
589
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
12.5
1152
9056
R4110
SPAT
NA
1.8
12.5
213
1177
S02
ICPC
Pruritus
1.7
12.4
240
1379
Z75.9
ICD-10 Finland
Unspecified problem related to medical facilities and other health care
4.6
12.4
42
90
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
12.4
638
4593
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
12.4
592
4209
S15
ICPC
Foreign body in skin
1.5
12.4
478
3261
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
1.7
12.4
257
1510
RK240
NOMESCO Finland
NA
128.0
12.3
13
*
H40.0
ICD-10 Finland
Glaucoma suspect
1.4
12.3
626
4499
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
3.0
12.3
71
236
XKC03
NOMESCO Finland
Water cystometry
1.7
12.2
250
1462
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
12.2
1022
7936
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.3
12.2
847
6404
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
12.1
2135
18023
SPAT1351
SPAT
Extensive ear examination
3.1
12.1
65
207
K59.0
ICD-10 Finland
Constipation
1.4
12.1
503
3486
XCD10
NOMESCO Finland
Electrophysiological examination of eye
1.7
12.0
227
1296
H82
ICPC
Vertiginous syndrome
2.0
12.0
142
689
N06AA09
ATC
amitriptyline; systemic
1.3
12.0
832
6291
L02
ICPC
Back symptom/complaint
1.4
12.0
581
4143
H70
ICPC
Otitis externa
2.1
11.9
130
609
J01MA14
ATC
moxifloxacin; systemic
1.4
11.9
710
5244
A29
ICPC
General symptom/complaint other
1.3
11.9
939
7230
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
11.9
1541
12612
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.1
11.9
136
649
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
2.1
11.9
130
612
RK321
NOMESCO Finland
NA
10.8
11.9
22
20
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
10.8
11.9
22
20
DCD10
NOMESCO Finland
Tympanoplasty
8.5
11.8
25
29
AXX01
SPAT
NA
2.1
11.8
126
584
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
13.1
11.8
20
15
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.3
11.8
757
5655
HMAK
NOMESCO Finland
NA
1.3
11.8
775
5815
R49.01
ICD-10 Finland
Functional dysphonia
1.8
11.7
201
1115
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.4
11.7
587
4214
R75
ICPC
Sinusitis acute/chronic
1.7
11.7
250
1481
L18
ICPC
Muscle pain
1.6
11.7
267
1614
B01AA03
ATC
warfarin; systemic
1.2
11.6
2404
20589
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.4
11.6
488
3388
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.4
11.6
658
4819
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.3
11.5
722
5371
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
11.5
2122
17985
WX290
NOMESCO Finland
Other blockade of nerve
1.2
11.5
2716
23533
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
11.4
915
7059
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.5
11.4
330
2116
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
11.4
327
2094
3898X
ICD-9 Finland
Deafness, Other specified forms of deafness
+∞
11.4
11
*
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
1.7
11.4
216
1237
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
11.4
390
2600
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.4
11.4
500
3502
R01AD11
ATC
triamcinolone; nasal
1.4
11.4
593
4284
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
11.4
594
4291
M10.9
ICD-10 Finland
Gout, unspecified
1.4
11.4
594
4294
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.6
11.3
254
1528
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.5
11.3
433
2955
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.6
11.3
321
2050
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
11.2
1375
11173
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.5
11.2
439
3006
G51.0
ICD-10 Finland
Bell palsy
1.8
11.2
181
984
N06AB10
ATC
escitalopram; oral
1.3
11.2
1220
9787
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.4
11.2
90
367
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
11.2
792
6005
B02.9
ICD-10 Finland
Zoster without complication
1.4
11.2
462
3201
G04BD09
ATC
trospium; oral
1.7
11.1
233
1373
U05
ICPC
Urination problems other
1.5
11.1
403
2716
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
11.1
501
3528
DDB00
NOMESCO Finland
Stapedectomy
8.2
11.1
24
29
R4130
NOMESCO Finland
Speech therapy
1.8
11.1
175
946
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
11.1
898
6938
R03BA01
ATC
beclometasone; inhalant
1.3
11.1
1128
8972
114
Kela drug reimbursment
Glaucoma
1.3
11.1
938
7293
XG474
NOMESCO Finland
Exhalation nntrogen oxide
1.9
11.1
160
837
R03BA02
ATC
budesonide; inhalant
1.2
11.0
1333
10824
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
11.0
478
3343
SPAT1281
SPAT
Other administrative function
1.4
11.0
599
4362
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.5
11.0
358
2360
H83.9
ICD-10 Finland
Disease of inner ear, unspecified
6.7
10.9
27
40
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.4
10.9
581
4211
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.4
10.9
642
4731
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
10.9
691
5151
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.6
10.9
299
1894
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.6
10.9
296
1873
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
10.9
557
4013
J01DC02
ATC
cefuroxime; systemic
1.5
10.8
360
2385
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.5
10.8
343
2248
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.0
10.8
126
608
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.7
10.8
226
1332
F16
ICPC
Eyelid symptom/complaint
1.5
10.8
315
2029
R07
ICPC
Sneezing/nasal congestion
1.5
10.7
315
2030
J45
ICD-10 Finland
Asthma
1.3
10.7
660
4900
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
10.7
3413
30239
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.4
10.7
487
3435
Z29.0
ICD-10 Finland
Isolation
3.7
10.7
45
120
S01.0
ICD-10 Finland
Open wound of scalp
1.4
10.7
622
4580
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
4.3
10.7
38
87
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
10.6
774
5890
3860A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Ménière's disease
8.1
10.6
23
28
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.3
10.6
863
6672
SPAT1234
SPAT
Support of social functional capacity
1.4
10.6
459
3206
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
17.5
10.6
16
9
38790
ICD-8 Finland
Other disease of ear and mastoid process, Degeneratio nervi acustici
9.4
10.6
21
22
G03CA04
ATC
estriol; systemic, vaginal
1.3
10.6
731
5523
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.7
10.6
210
1219
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.3
10.5
17
626
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.3
10.5
647
4803
-30
ICPC
Medical examin/health eval complete
1.6
10.5
237
1429
U07
ICPC
Urine symptom/complaint other
1.4
10.5
463
3248
M75
ICD-10 Finland
Shoulder lesions
1.6
10.5
276
1732
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.3
10.5
747
5668
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
10.5
290
1844
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
10.5
887
6896
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
10.4
384
2597
C03EA02
ATC
trichlormethiazide and potassium-sparing agents; oral
1.7
10.4
214
1255
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.2
10.4
1184
9543
J20
ICD-10 Finland
Acute bronchitis
1.3
10.4
675
5051
A27
ICPC
Fear of other disease NOS
1.5
10.4
342
2261
38910
ICD-8 Finland
Other deafness, Deafness, one ear and partial deafness in other
+∞
10.3
10
*
38809
ICD-8 Finland
Deaf mutism, Unspecified
+∞
10.3
10
*
3890A
ICD-9 Finland
Deafness, Conductive deafness
+∞
10.3
10
*
WX402
NOMESCO Finland
General anaesthesia
1.3
10.3
1105
8840
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
3.4
10.3
49
144
N39.3
ICD-10 Finland
Stress incontinence
1.4
10.3
504
3603
D19
ICPC
Teeth/gum symptom/complaint
1.2
10.3
1648
13768
P03
ICPC
Feeling depressed
1.4
10.3
405
2779
M05BA04
ATC
alendronic acid; oral
1.3
10.3
840
6498
R83
ICPC
Respiratory infection other
1.2
10.3
1181
9531
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
10.3
2076
17724
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.4
10.3
461
3246
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.5
10.2
342
2269
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.3
10.2
20
671
N06AB04
ATC
citalopram; systemic
1.2
10.2
1708
14327
R06AX22
ATC
ebastine; oral
1.3
10.2
1069
8534
M15
ICD-10 Finland
Polyarthrosis
1.5
10.2
387
2636
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.6
10.2
255
1581
R12
ICD-10 Finland
Heartburn
1.4
10.2
461
3249
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.4
10.1
461
3254
C10AA03
ATC
pravastatin; oral
1.3
10.1
671
5039
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
10.4
10.1
19
18
S02.51
ICD-10 Finland
Fracture of tooth, open
1.3
10.1
620
4599
K86
ICPC
Hypertension uncomplicated
1.3
10.1
1027
8166
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.0
10.1
126
628
F06.7
ICD-10 Finland
Mild cognitive disorder
1.6
10.1
241
1474
K96
ICPC
Haemorrhoids
1.8
10.1
156
840
L90
ICPC
Osteoarthrosis of knee
1.4
10.1
491
3508
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.7
10.0
222
1333
D17
ICPC
Incontinence of bowel
2.4
10.0
81
330
XQ848
NOMESCO Finland
Dermatological photography
1.7
10.0
198
1154
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
10.0
289
1857
N03AE01
ATC
clonazepam; systemic
1.4
10.0
418
2908
K05
ICPC
Irregular heartbeat other
1.6
9.9
254
1585
WX140
NOMESCO Finland
Parabulbar anesthesy
1.5
9.9
380
2598
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
9.9
288
1855
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.5
9.8
294
1905
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
2.0
9.8
117
572
R01BA01
ATC
phenylpropanolamine; oral
1.5
9.8
362
2450
H92.2
ICD-10 Finland
Otorrhagia
6.3
9.8
25
39
ZYC03
NOMESCO Finland
Remote contact, text-based
2.9
9.8
58
199
UJF30
NOMESCO Finland
Ileoscopy through colon
1.3
9.8
674
5092
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
9.8
1641
13769
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
9.7
833
6484
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
9.7
983
7815
C01CA24
ATC
epinephrine; parenteral
1.5
9.7
309
2031
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
2.5
9.7
76
305
K02
ICPC
Pressure/tightness of heart
1.7
9.7
181
1037
R04
ICPC
Breathing problem other
1.6
9.7
230
1408
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.3
9.6
806
6254
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
1.4
9.6
433
3051
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
3.6
9.6
42
116
H31
ICPC
Ear, Medical examin/health eval partial
5.3
9.6
28
52
G04BD07
ATC
tolterodine; oral
1.4
9.6
486
3494
-45
ICPC
Observ/health educat/advice/diet
1.6
9.6
236
1458
C10AA04
ATC
fluvastatin; oral
1.3
9.6
894
7034
ZXC10
NOMESCO Finland
Use of laser
1.8
9.6
148
796
L72.1
ICD-10 Finland
Trichilemmal cyst
1.4
9.6
424
2979
J45.8
ICD-10 Finland
Mixed asthma
1.6
9.6
226
1383
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.4
9.5
387
2674
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.4
9.5
462
3299
R03AK08
ATC
formoterol and beclometasone; inhalant
1.6
9.5
235
1452
A03CA02
ATC
clidinium and psycholeptics; oral
1.4
9.5
550
4045
WX144
NOMESCO Finland
Subconjunctival anesthesy
2.0
9.5
116
571
R08
ICPC
Nose symptom/complaint other
1.7
9.5
191
1116
L29.9
ICD-10 Finland
Pruritus, unspecified
1.8
9.5
166
931
N30.9
ICD-10 Finland
Cystitis, unspecified
1.4
9.5
469
3363
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.5
9.4
307
2025
H69.8
ICD-10 Finland
Other specified disorders of Eustachian tube
4.6
9.4
31
66
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
9.4
424
2990
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
9.4
474
3409
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
9.4
1247
10222
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
98.5
9.3
10
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.4
9.3
42
981
SPAT1081
SPAT
Cardiorespiratory global assessment
1.4
9.3
494
3581
L11
ICPC
Wrist symptom/complaint
1.4
9.3
478
3448
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
9.3
286
1864
3897B
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDOMUTITAS]
+∞
9.3
9
*
3883A
ICD-9 Finland
Other disorders of ear, Tinnitus
+∞
9.3
9
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
29.5
9.3
12
*
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.5
9.3
302
1996
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.5
9.3
314
2094
DFF20
NOMESCO Finland
Audiometry for children
21.3
9.3
13
6
K07.60
ICD-10 Finland
Snapping jaw
1.6
9.2
219
1340
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.2
9.2
1636
13793
D06BX01
ATC
metronidazole; topical
1.3
9.2
697
5337
R33
ICD-10 Finland
Retention of urine
1.3
9.2
783
6091
L29
ICPC
Musculoskeletal sympt/complt other
1.3
9.2
549
4060
J01MA12
ATC
levofloxacin; systemic
1.2
9.2
1649
13918
104
Kela drug reimbursment
Thyroid insufficiency
1.3
9.2
567
4215
I49.1
ICD-10 Finland
Atrial premature depolarization
1.6
9.2
241
1514
A08
ICPC
Swelling
1.5
9.2
349
2380
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.3
9.2
599
4493
K07
ICPC
Swollen ankles/oedema
1.4
9.1
394
2755
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.4
9.1
419
2966
R44
ICPC
Respiratory, Preventive immunization/medic
1.8
9.1
140
752
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.6
9.1
248
1575
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
9.1
339
2306
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.4
9.1
429
3054
DFF05
SPAT
NA
3.9
9.0
35
88
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.4
9.0
357
2458
L05
ICPC
Flank/axilla symptom/complaint
1.4
9.0
385
2687
SPAT1359
SPAT
Use of symptom diary
1.7
9.0
181
1062
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
1.8
8.9
156
876
R03BC03
ATC
nedocromil; inhalant
1.4
8.9
484
3521
D07AA02
ATC
hydrocortisone; topical
1.3
8.9
950
7594
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.8
8.9
148
815
K03.66
ICD-10 Finland
Tooth plaque
1.4
8.9
401
2826
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
1.5
8.9
280
1836
G04BD11
ATC
fesoterodine; oral
1.5
8.9
260
1677
B81
ICPC
Anaemia vit B12/folate deficiency
1.5
8.9
340
2324
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
8.9
381
2664
SPAT1101
SPAT
Orthostatic test
1.4
8.9
414
2937
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
2.4
8.9
72
298
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
8.9
748
5812
F03
ICPC
Eye discharge
1.4
8.9
369
2563
F02
ICPC
Red eye
1.5
8.8
282
1855
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.3
8.8
534
3955
ACC51
NOMESCO Finland
Release of median nerve
1.4
8.8
461
3334
H10
ICD-10 Finland
Conjunctivitis
1.4
8.8
342
2344
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.6
8.8
226
1414
R60.9
ICD-10 Finland
Oedema, unspecified
1.4
8.8
381
2669
WX704
NOMESCO Finland
Intubation
1.4
8.7
478
3486
K04
ICPC
Palpitations/awareness of heart
1.4
8.7
337
2313
ZY010
NOMESCO Finland
Hospital outpatient
1.6
8.7
240
1529
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
8.6
466
3390
DFD20
NOMESCO Finland
Closure of rupture of round window
49.2
8.6
10
*
SPAT1039
SPAT
Otomicroscopy
2.0
8.6
107
533
W10
ICD-10 Finland
Fall on and from stairs and steps
1.4
8.6
360
2503
J30.3
ICD-10 Finland
Other allergic rhinitis
1.7
8.6
165
952
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.5
8.6
282
1869
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
1.6
8.6
219
1370
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
8.6
196
1191
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
8.5
691
5339
G25.0
ICD-10 Finland
Essential tremor
1.6
8.5
192
1163
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.3
8.5
611
4647
H53.2
ICD-10 Finland
Diplopia
1.6
8.5
216
1349
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
8.5
1188
9790
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
11.4
8.5
15
13
L60.0
ICD-10 Finland
Ingrowing nail
1.5
8.4
283
1883
N62
ICD-10 Finland
Hypertrophy of breast
1.6
8.4
209
1298
S01AD03
ATC
aciclovir; ophthalmic
1.5
8.4
268
1765
M77.4
ICD-10 Finland
Metatarsalgia
1.5
8.4
309
2095
R49.08
ICD-10 Finland
Other specified dysphonia
1.8
8.4
134
732
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
2.4
8.4
68
281
N06AX16
ATC
venlafaxine; oral
1.3
8.4
757
5939
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
88.6
8.4
9
*
M10
ICD-10 Finland
Gout
1.4
8.3
354
2472
R23.3
ICD-10 Finland
Spontaneous ecchymoses
1.7
8.3
150
850
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.4
8.3
331
2283
NBG10
NOMESCO Finland
Acromioplastia
1.6
8.3
200
1233
XA402
NOMESCO Finland
ENMG
1.7
8.3
168
988
T92
ICPC
Gout
1.7
8.3
161
936
R49.09
ICD-10 Finland
Unspecified dysphonia
2.2
8.3
79
353
Z01.7
ICD-10 Finland
Laboratory examination
1.3
8.3
819
6495
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
1.8
8.3
125
670
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.4
8.3
448
3263
M54.1
ICD-10 Finland
Radiculopathy
1.5
8.2
243
1573
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
8.2
1298
10818
S97
ICPC
Chronic ulcer skin
1.4
8.2
469
3447
DEA10
NOMESCO Finland
Attico-antrotomy
8.4
8.2
17
20
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.4
8.2
435
3160
RD211
NOMESCO Finland
NA
1.4
8.2
322
2218
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.2
8.2
1120
9206
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
1.6
8.2
214
1347
U71
ICPC
Cystitis/urinary infection other
1.4
8.1
421
3042
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.8
8.1
139
775
H40.11
ICD-10 Finland
Low pressure glaucoma
1.6
8.1
183
1109
E000007
ATC
NA
1.4
8.1
348
2435
WX780
NOMESCO Finland
Remote monitoring CPAP
1.6
8.1
212
1333
S08
ICPC
Skin colour change
1.4
8.1
366
2586
S01
ICPC
Pain/tenderness of skin
1.5
8.1
292
1973
N41.0
ICD-10 Finland
Acute prostatitis
1.8
8.1
137
763
K22
ICPC
Risk factor cardiovascular disease
1.4
8.1
431
3133
L86
ICPC
Back syndrome with radiating pain
1.4
8.1
375
2664
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
8.0
774
6116
DFF00
SPAT
NA
3.8
8.0
32
83
D07AD01
ATC
clobetasol; topical
1.2
8.0
1117
9193
M01AH01
ATC
celecoxib; oral (coxibs)
1.2
8.0
1462
12346
R30.0
ICD-10 Finland
Dysuria
1.5
8.0
242
1573
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.2
8.0
7
368
S80.0
ICD-10 Finland
Contusion of knee
1.4
8.0
395
2835
C02AC05
ATC
moxonidine; oral
1.4
8.0
388
2774
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
1.9
8.0
119
634
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.3
8.0
463
3409
M79.7
ICD-10 Finland
Fibromyalgia
1.7
8.0
165
976
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
8.0
816
6492
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
8.0
1376
11559
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
1.7
8.0
142
804
K29
ICPC
Cardiovascular sympt/complt other
1.4
8.0
356
2507
SPAT1059
SPAT
Spirometry at the office
1.4
8.0
378
2690
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
8.0
841
6715
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
16.9
8.0
12
7
TQW40
SPAT
NA
1.6
8.0
204
1276
M05BX04
ATC
denosumab; parenteral
1.4
8.0
417
3021
TPH07
NOMESCO Finland
Cathetrisation of artery
1.2
8.0
873
7005
TKD00
NOMESCO Finland
Dilatation of urethra
2.2
8.0
79
360
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
4.6
7.9
26
56
R06AX13
ATC
loratadine; oral
1.2
7.9
912
7355
XA410
NOMESCO Finland
BAEP
21.7
7.9
11
5
K03.80
ICD-10 Finland
Irradiated enamel
1.5
7.9
224
1434
XW000
NOMESCO Finland
Bone marrow biopsy
1.4
7.9
317
2190
EBA00
NOMESCO Finland
Extraction of tooth
1.1
7.9
2386
20980
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.6
7.9
189
1166
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.5
7.9
225
1446
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.7
7.9
151
873
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.1
7.9
88
422
R81
ICPC
Pneumonia
1.5
7.9
237
1541
H02.4
ICD-10 Finland
Ptosis of eyelid
1.6
7.9
206
1298
S09
ICPC
Infected finger/toe
1.6
7.8
201
1258
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.5
7.8
267
1787
A10BB01
ATC
glibenclamide; oral
0.7
7.8
316
4245
C07AA05
ATC
propranolol; systemic
1.2
7.8
1259
10514
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
1.7
7.8
152
883
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.5
7.8
233
1513
EMAK
NOMESCO Finland
NA
1.5
7.8
230
1493
ZY010
SPAT
NA
2.4
7.7
64
268
S20.2
ICD-10 Finland
Contusion of thorax
1.4
7.7
337
2366
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.3
7.7
474
3527
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.4
7.7
22
615
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.3
7.7
754
5974
G44.8
ICD-10 Finland
Other specified headache syndromes
2.4
7.7
63
261
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.5
7.7
235
1537
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.4
7.7
343
2419
R01AX03
ATC
ipratropium bromide; nasal
1.6
7.7
188
1166
H86
ICPC
Deafness
44.3
7.6
9
*
D09
ICPC
Nausea
1.5
7.6
221
1427
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.3
7.6
478
3566
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
1.6
7.6
186
1151
R01AD05
ATC
budesonide; nasal
1.3
7.6
505
3799
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.4
7.6
307
2123
G50.0
ICD-10 Finland
Trigeminal neuralgia
1.8
7.6
112
599
M50.3
ICD-10 Finland
Other cervical disc degeneration
1.7
7.6
136
772
A03FA01
ATC
metoclopramide; systemic, rectal
1.2
7.6
1674
14368
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
7.3
7.6
17
23
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.5
7.6
217
1400
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.6
7.6
182
1124
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.5
7.5
56
221
H66
ICD-10 Finland
Suppurative and unspecified otitis media
1.9
7.5
105
548
J02AC02
ATC
itraconazole; systemic
1.2
7.5
1262
10574
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
1.6
7.5
193
1212
S70
ICPC
Herpes zoster
1.6
7.5
183
1131
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.4
7.5
430
3163
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
24.6
7.5
10
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.3
7.5
448
3318
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.6
7.5
170
1035
H76
ICPC
Foreign body in ear
2.6
7.5
52
198
R5110
SPAT
NA
1.5
7.4
208
1334
R52.0
ICD-10 Finland
Acute pain
1.6
7.4
181
1122
SPF30
NOMESCO Finland
Soling for prothesis
1.6
7.4
161
967
B03BA03
ATC
hydroxocobalamin; parenteral
1.3
7.4
549
4196
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
2.4
7.4
59
243
N29
ICPC
Neurological sympt/complt other
1.7
7.4
138
792
Z04
ICD-10 Finland
Examination and observation for other reasons
1.8
7.4
122
677
R01AC01
ATC
cromoglicic acid; nasal
1.6
7.4
179
1108
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
7.4
557
4266
H05
ICPC
Bleeding ear
3.0
7.4
39
127
I50
ICD-10 Finland
Heart failure
1.4
7.4
321
2256
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
7.4
239
1584
SPAT1232
SPAT
Communication with help of interpreter or assistant
3.7
7.4
30
80
ZX198
NOMESCO Finland
Other local administration
2.0
7.4
93
468
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.4
7.4
393
2860
Y85
ICPC
Benign prostatic hypertrophy
1.8
7.4
127
715
WW200
SPAT
NA
1.3
7.4
609
4723
M01AC01
ATC
piroxicam; systemic, rectal
1.2
7.4
1118
9286
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.6
7.3
191
1202
SPAT1251
SPAT
Organisation of medication
1.4
7.3
326
2297
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
7.3
219
1425
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.4
7.3
363
2609
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.5
7.3
256
1721
SPAT1360
SPAT
Extensive global examination
1.3
7.3
606
4699
DHB50
NOMESCO Finland
Turbinoplasty
1.7
7.3
130
736
TKE00
NOMESCO Finland
Needle biopsy of prostate
1.4
7.3
399
2912
DCA40
NOMESCO Finland
Fat patching or other similar technique without opening of tympanic membrane
13.1
7.3
12
9
R41.0
ICD-10 Finland
Disorientation, unspecified
1.4
7.3
286
1971
N03AX11
ATC
topiramate; oral
1.8
7.3
113
614
R06.4
ICD-10 Finland
Hyperventilation
1.9
7.3
97
500
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
1.6
7.3
198
1259
H93.3
ICD-10 Finland
Disorders of acoustic nerve
+∞
7.2
7
*
38800
ICD-8 Finland
Deaf mutism, Acquisita
+∞
7.2
7
*
L04AA06
ATC
mycophenolic acid; systemic
1.9
7.2
96
493
J01MA06
ATC
norfloxacin; oral
1.2
7.2
1106
9192
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.3
7.2
674
5312
C10AX09
ATC
ezetimibe; oral
1.2
7.2
831
6711
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.4
7.2
358
2577
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
1.3
7.2
568
4382
130
Kela drug reimbursment
Malignant tumour
0.8
7.2
491
6137
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
7.2
294
2043
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
1.7
7.1
132
758
S01ED51
ATC
timolol, combinations; ophthalmic
1.3
7.1
712
5656
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
1.5
7.1
221
1449
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
7.1
176
1097
K25
ICPC
Fear of hypertension
1.4
7.1
278
1915
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.5
7.1
210
1362
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
2.1
7.1
73
339
D06BB10
ATC
imiquimod; topical
1.4
7.1
324
2294
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.4
7.1
310
2179
Y94.0
ICD-10 Finland
Accident at home
1.7
7.1
149
888
E000001
ATC
NA
1.2
7.1
1529
13096
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
2.5
7.1
53
211
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.2
7.1
777
6242
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.5
7.1
238
1591
H57.1
ICD-10 Finland
Ocular pain
1.6
7.1
170
1049
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
1.8
7.0
122
687
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.4
7.0
384
2805
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.3
7.0
505
3845
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
4.0
7.0
26
64
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.4
7.0
278
1918
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.4
7.0
354
2552
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.3
7.0
62
270
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
7.0
531
4076
R25.2
ICD-10 Finland
Cramp and spasm
1.7
7.0
138
810
R5130
SPAT
NA
4.3
7.0
24
55
-60
ICPC
Result test/procedure
1.3
7.0
462
3477
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.4
7.0
336
2407
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
1.6
7.0
163
1002
F01
ICPC
Eye pain
1.6
7.0
156
946
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.5
6.9
190
1214
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.7
6.9
132
766
NH3EA
NOMESCO Finland
Feet X-ray examination with load
1.7
6.9
123
699
XKX00
NOMESCO Finland
Pelvic floor electromyography
3.3
6.9
32
95
TQW80
NOMESCO Finland
Local dermatologic skincare
1.6
6.9
188
1198
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
1.9
6.9
98
517
C09CA03
ATC
valsartan; oral
1.2
6.9
712
5677
C09DA01
ATC
losartan and diuretics; oral
1.2
6.9
858
6983
D16
ICPC
Rectal bleeding
1.7
6.9
142
842
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.3
6.9
17
505
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.4
6.9
30
706
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.5
6.9
230
1535
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.3
6.9
575
4468
H25.0
ICD-10 Finland
Senile incipient cataract
1.3
6.9
540
4163
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.3
6.8
489
3721
S12
ICPC
Insect bite/sting
1.3
6.8
563
4370
R44.0
ICD-10 Finland
Auditory hallucinations
3.4
6.8
31
91
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.2
6.8
756
6080
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.6
6.8
100
1627
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.5
6.8
202
1313
G45.4
ICD-10 Finland
Transient global amnesia
1.6
6.8
169
1052
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.2
6.8
893
7313
A46
ICD-10 Finland
Erysipelas
1.2
6.8
1211
10210
L10
ICPC
Elbow symptom/complaint
1.5
6.8
249
1696
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.5
6.8
230
1543
SPAT1291
SPAT
Other function in accordance with NCSP classification
1.7
6.8
118
669
S01.3
ICD-10 Finland
Open wound of ear
2.0
6.7
84
422
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
6.7
638
5036
XKD03
NOMESCO Finland
Urethral pressure profilometry
1.6
6.7
178
1126
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.4
6.7
277
1926
L09
ICPC
Arm symptom/complaint
1.4
6.7
254
1738
WX400
NOMESCO Finland
Inhalation anesthesy
1.5
6.7
228
1529
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
6.7
1574
13569
R5140
SPAT
NA
2.6
6.7
47
180
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.1
6.7
2139
18856
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.2
6.7
747
6009
B01AE07
ATC
dabigatran etexilate; oral
1.4
6.7
329
2366
G45.3
ICD-10 Finland
Amaurosis fugax
1.6
6.7
153
933
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
1.6
6.7
143
857
ZA1.0
ICD-10 Finland
Shoulder region
1.6
6.7
153
935
R52.2
ICD-10 Finland
Other chronic pain
1.5
6.7
202
1322
M65.3
ICD-10 Finland
Trigger finger
1.5
6.7
249
1700
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
4.1
6.7
24
58
Z2445
NOMESCO Finland
Psychologist
1.6
6.7
174
1100
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.3
6.6
658
5220
N06AX26
ATC
vortioxetine; oral
1.4
6.6
262
1811
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.7
6.6
144
2156
J01
ICD-10 Finland
Acute sinusitis
1.5
6.6
236
1598
SPAT1098
SPAT
Exercise ECG
1.6
6.6
148
899
-50
ICPC
Medication/prescr/renewal
1.4
6.6
331
2387
N06DX01
ATC
memantine; oral
1.2
6.6
694
5543
S61.1
ICD-10 Finland
Open wound of finger(s) with damage to nail
1.7
6.6
129
755
4161
FHL
Exploratory tympanotomy
22.1
6.6
9
*
DFX03
SPAT
NA
22.1
6.6
9
*
R06.2
ICD-10 Finland
Wheezing
1.4
6.6
267
1854
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
1.7
6.6
134
793
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.5
6.6
222
1484
N05BA12
ATC
alprazolam; oral
1.2
6.6
709
5683
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.3
6.6
406
3026
ZXE20
NOMESCO Finland
More than three and less than five hours
1.2
6.6
1157
9740
H46
ICD-10 Finland
Optic neuritis
2.5
6.6
47
184
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.5
6.6
245
1671
F70
ICPC
Conjunctivitis infectious
1.7
6.6
127
743
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.2
6.5
969
8029
B02
ICD-10 Finland
Zoster [herpes zoster]
1.4
6.5
256
1768
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.2
6.5
822
6704
J01FA15
ATC
telithromycin; oral
1.3
6.5
604
4758
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
6.5
1631
14133
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.3
6.5
595
4677
A07EC01
ATC
sulfasalazine; oral, rectal
1.3
6.5
543
4220
SPAT1240
SPAT
Therapeutic discussion
1.3
6.5
493
3787
F05.9
ICD-10 Finland
Delirium, unspecified
1.5
6.5
180
1154
A69.2
ICD-10 Finland
Lyme disease
1.4
6.5
311
2226
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
1.3
6.5
395
2939
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.3
6.5
430
3239
81
HP
Angiography of the heart and coronary arteries
1.2
6.5
692
5541
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
1.7
6.5
126
738
50499
ICD-8 Finland
Deflected nasal septum
1.7
6.5
136
812
C10AC01
ATC
colestyramine; oral
1.6
6.5
172
1093
H73.1
ICD-10 Finland
Chronic myringitis
8.5
6.5
13
15
XG405
NOMESCO Finland
Education on PEF monitoring
1.8
6.5
100
544
D01AE15
ATC
terbinafine; topical
1.3
6.5
526
4075
359
Kela drug reimbursment
Mirabegroni
2.3
6.5
55
234
S26
ICPC
Fear of cancer of skin
1.9
6.4
86
445
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
1.9
6.4
84
432
M19.8
ICD-10 Finland
Other specified arthrosis
1.5
6.4
223
1503
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.5
6.4
196
1283
S00.0
ICD-10 Finland
Superficial injury of scalp
1.6
6.4
157
975
ZXC60
NOMESCO Finland
Application of heat
1.9
6.4
82
419
L83
ICPC
Neck syndrome
2.3
6.4
55
236
IHA10
SPAT
NA
2.9
6.4
35
118
R31
NOMESCO Finland
Adaptation training
4.2
6.4
22
51
M01AH03
ATC
valdecoxib; oral
1.3
6.4
426
3215
N81.6
ICD-10 Finland
Rectocele
1.3
6.4
422
3179
H93.0
ICD-10 Finland
Degenerative and vascular disorders of ear
68.7
6.4
7
*
D21
ICPC
Swallowing problem
1.8
6.4
107
599
A31
ICPC
General and Unspecified, Medical examin/health eval partial
1.5
6.4
182
1177
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.2
6.4
727
5863
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.2
6.4
1430
12282
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
6.4
607
4799
M24.9
ICD-10 Finland
Joint derangement, unspecified
2.8
6.4
38
135
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
1.6
6.4
140
848
B82
ICPC
Anaemia other/unspecified
1.5
6.3
186
1207
M01AX01
ATC
nabumetone; oral
1.4
6.3
324
2346
S02.5
ICD-10 Finland
Fracture of tooth
1.6
6.3
156
970
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
3.4
6.3
28
81
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
14.1
6.3
10
7
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.4
6.3
236
1612
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
2.2
6.3
58
259
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.2
6.3
822
6722
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
1.8
6.3
97
528
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.3
6.3
409
3073
F92
ICPC
Cataract
2.2
6.3
60
272
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
4.6
6.3
20
43
K76
ICPC
Ischaemic heart dis without angina
1.5
6.3
208
1390
UDQ02
NOMESCO Finland
Direct laryngoscopy
2.3
6.3
54
232
G04BD04
ATC
oxybutynin; oral, transdermal
1.3
6.3
505
3907
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.2
6.3
1223
10389
SPAT1016
SPAT
Examination of vision
1.4
6.2
313
2260
K90.0
ICD-10 Finland
Coeliac disease
1.5
6.2
168
1072
H72
ICD-10 Finland
Perforation of tympanic membrane
4.8
6.2
19
39
L95
ICPC
Osteoporosis
1.4
6.2
235
1611
A10
ICPC
Bleeding/haemorrhage NOS
2.1
6.2
62
286
D40
ICPC
Digestive, Diagnostic endoscopy
2.8
6.2
37
131
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
2.0
6.2
69
333
AS4
HP
Physiological pacemaker insertion DDD (R)
1.6
6.2
137
832
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.9
6.2
84
438
J01CA02
ATC
pivampicillin; oral
1.5
6.2
184
1198
D06BB03
ATC
aciclovir; topical
1.4
6.2
297
2128
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
1.6
6.2
148
918
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
2.1
6.2
62
289
S02AA03
ATC
boric acid; otic
2.0
6.2
67
323
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.4
6.1
228
1557
SBB10
NOMESCO Finland
Teeth copy
1.4
6.1
291
2080
D07CC01
ATC
betamethasone and antibiotics; topical
1.2
6.1
910
7541
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
1.7
6.1
119
697
RK323
NOMESCO Finland
NA
3.2
6.1
29
89
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.4
6.1
249
1735
M09AX01
ATC
hyaluronic acid; parenteral
1.3
6.1
459
3522
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.4
6.1
246
1711
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
1.7
6.1
127
757
D10
ICPC
Vomiting
1.5
6.1
220
1496
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.3
6.1
391
2936
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.3
6.1
382
2860
DGW00
NOMESCO Finland
Dilatation of eustachian tube
6.2
6.1
15
24
D01AC02
ATC
miconazole; topical
1.2
6.1
653
5236
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
1.7
6.1
115
670
B37.0
ICD-10 Finland
Candidal stomatitis
2.0
6.1
68
331
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.5
6.0
184
1205
RS130
NOMESCO Finland
NA
5.2
6.0
17
32
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
2.3
6.0
51
220
KED33
NOMESCO Finland
Transurethral incision of prostate
1.7
6.0
111
639
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.2
6.0
692
5586
M77.1
ICD-10 Finland
Lateral epicondylitis
1.4
6.0
307
2222
R07.2
ICD-10 Finland
Precordial pain
1.6
6.0
143
882
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
1.4
6.0
256
1796
K92.1
ICD-10 Finland
Melaena
1.3
6.0
460
3538
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.3
6.0
525
4109

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023103) Potassium [Moles/volume] in Serum or Plasma
11355
96942
2.32
200.58
22.9
20.1
mmol/l
4.0
4.0
0.06
11060
93986
(3019550) Sodium [Moles/volume] in Serum or Plasma
11338
96756
2.31
200.15
22.7
19.9
mmol/l
139.5
139.5
0.53
11065
93976
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
10959
92603
2.12
192.90
19.1
16.9
mg/l
24.3
26.9
13.73
9182
75691
(40761511) CBC panel - Blood by Automated count
11076
94294
2.13
185.81
19.5
15.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10074
83651
1.86
172.46
5.2
4.7
mu/l
2.0
2.1
1.87
8856
75098
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11251
97026
2.14
171.54
11.8
10.9
u/l
24.6
25.1
1.52
10645
92731
(3035941) MCH [Entitic mass]
11553
100672
2.29
171.51
27.9
24.4
pg
30.4
30.4
1.22
11363
98629
(3007461) Platelets [#/volume] in Blood
11550
100643
2.29
171.35
28.0
24.5
e9/l
238.7
244.3
16.91
11232
97295
(3010813) Leukocytes [#/volume] in Blood
11555
100705
2.29
171.33
28.1
24.5
e9/l
7.0
6.9
0.53
11190
96940
(3024731) MCV [Entitic volume]
11553
100681
2.29
171.32
27.9
24.4
fl
91.6
91.6
0.97
11362
98640
(3026361) Erythrocytes [#/volume] in Blood
11553
100686
2.29
171.21
28.0
24.5
e12/l
4.4
4.4
6.73
11185
96899
(3000963) Hemoglobin [Mass/volume] in Blood
11554
100704
2.29
171.09
28.2
24.7
g/l
132.1
132.7
3.75
11356
98661
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
9198
74642
1.75
166.53
7.8
7.6
u/l
80.1
81.2
0.96
8483
69863
(3013707) Erythrocyte sedimentation rate by Westergren method
8664
69183
1.71
166.09
4.6
4.1
mm/h
14.1
14.5
1.51
7761
63144
(3031040) Bacteria [#/volume] in Urine by Automated count
8345
66040
1.69
164.66
5.7
5.0
e6/l
1580.4
1770.4
0.14
164
1112
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6405
47521
1.65
160.83
6.3
6.0
mmol/l
1.2
1.2
1.88
5678
42668
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5536
39791
1.65
156.00
4.6
4.0
ng/l
67.9
82.2
0.31
4217
29820
(3037467) Urinalysis macro (dipstick) panel - Urine
8368
66926
1.66
151.74
5.1
4.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
10107
85174
1.78
149.51
6.6
6.3
mmol/mol
40.9
40.7
1.07
8947
77399
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
10436
88911
1.83
147.12
5.2
4.9
mmol/l
6.0
6.1
0.56
8907
79340
(3013826) Glucose [Moles/volume] in Serum or Plasma
7502
58878
1.61
142.04
5.1
4.7
mmol/l
6.8
6.9
0.83
7100
55137
(3002385) Erythrocyte distribution width [Ratio]
9070
74768
1.66
138.76
23.1
20.7
%
13.9
13.9
0.81
8858
72914
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6807
52493
1.58
136.33
6.9
6.6
mmol/l
1.2
1.2
2.09
5426
43867
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
10523
90574
1.79
134.01
5.4
5.1
mmol/l
2.5
2.6
11.30
9103
81816
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
8444
68752
1.61
131.99
4.2
3.9
pmol/l
15.1
15.0
1.99
7340
61340
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5337
39196
1.58
129.70
2.3
2.2
nmol/l
80.2
79.1
1.88
4598
34311
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
10264
87965
1.74
129.49
4.8
4.5
mmol/l
4.4
4.5
13.56
9002
79768
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
10079
86172
1.70
125.56
18.7
16.2
ml/min/173m2
72.3
74.2
16.13
8543
71317
(3032080) INR in Blood by Coagulation assay
5804
43791
1.55
123.03
12.9
10.4
inr
1.3
1.3
0.85
2052
11954
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
10139
87098
1.69
120.72
4.8
4.5
mmol/l
1.4
1.5
3.15
8740
78456
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4664
33742
1.56
117.69
3.3
3.1
ng/l
1972.2
1940.1
0.14
3913
29306
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9808
84148
1.62
110.38
4.2
4.0
mmol/l
1.3
1.3
0.90
8368
75026
(3009261) Glucose [Presence] in Urine by Test strip
6072
47242
1.50
105.32
4.3
4.0
estimate
0.0
0.0
1.72
1504
8556
(3021601) Nitrite [Presence] in Urine by Test strip
6002
46673
1.50
103.81
5.5
5.3
estimate
0.0
0.0
0.80
1517
8717
(3041096) Erythrocytes [Presence] in Urine by Automated
3474
24040
1.58
103.52
4.2
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
5993
46617
1.49
103.32
4.3
3.9
estimate
0.0
0.0
0.80
1478
8687
(3044889) 12 lead EKG panel
8112
67118
1.51
103.19
4.6
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
6522
51760
1.49
100.77
5.8
6.0
umol/l
12.3
12.1
0.29
6123
48941
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4192
30448
1.52
99.53
2.6
2.5
u/l
59.4
59.5
0.04
3796
27962
(3021589) Normoblasts [#/volume] in Blood
5440
41884
1.48
96.29
12.5
10.1
e9/l
0.0
0.0
0.37
4533
33912
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
3219
22215
1.57
95.69
1.8
1.7
pmol/l
30581752.0
21147428.3
0.42
2374
17960
(3029937) Albumin [Presence] in Urine by Test strip
3585
25375
1.54
94.98
4.8
4.4
estimate
0.0
0.0
0.43
1454
8276
(42870588) Differential panel, method unspecified - Blood
4451
33095
1.49
92.77
5.8
5.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1036
5225
2.03
92.00
2.4
2.3
au/ml
33.3
25.7
0.59
33
210
(3018418) pH of Serum or Plasma
4308
31905
1.49
91.15
4.6
4.0
ph
7.4
7.4
2.26
1010
5945
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5074
38854
1.47
90.53
3.2
2.9
ug/l
155.6
149.7
0.33
4444
35286
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
940
4688
2.05
85.90
1.3
1.3
au/ml
47.8
53.0
0.18
32
192
(3002582) Erythrocytes [#/volume] in Urine
4384
32902
1.47
85.30
3.9
3.4
e6/l
136.2
100.4
0.39
3445
25449
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4637
35189
1.46
85.15
4.6
4.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
5636
44475
1.44
83.48
6.2
5.8
%
2.8
2.8
0.82
5179
41020
(40761536) Microorganisms panel - Urine sediment
1407
8102
1.79
83.00
5.3
4.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
4848
37274
1.45
82.28
4.7
3.9
e6/l
127.3
129.9
0.06
3644
26995
(3022096) Basophils/100 leukocytes in Blood
5497
43259
1.44
82.22
6.2
5.9
%
0.7
0.6
0.56
5046
39951
(3019069) Monocytes/100 leukocytes in Blood
5651
44710
1.43
81.99
6.5
6.1
%
8.9
8.8
1.69
5206
41391
(3021960) Folate [Moles/volume] in Serum or Plasma
3538
25715
1.49
79.75
1.6
1.6
nmol/l
20.8
20.0
1.92
2886
22003
(3013115) Eosinophils [#/volume] in Blood
6037
48495
1.42
79.63
6.1
5.8
e9/l
0.2
0.2
0.41
5246
41634
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5553
43991
1.42
78.94
2.2
2.1
pmol/l
94.2
93.0
1.12
2830
22749
(3002030) Lymphocytes/100 leukocytes in Blood
5722
45622
1.42
78.19
6.3
6.0
%
26.0
26.2
0.45
5230
41981
(3024561) Albumin [Mass/volume] in Serum or Plasma
5702
45573
1.41
76.11
4.8
4.7
g/l
34.7
34.5
1.69
5147
41810
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1780
11188
1.65
75.95
4.2
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
5838
46884
1.41
75.64
5.9
5.6
e9/l
0.6
0.6
1.21
4994
39596
(3018010) Neutrophils/100 leukocytes in Blood
5624
44879
1.41
75.54
6.0
5.8
%
58.8
58.6
0.64
5153
41507
(3006315) Basophils [#/volume] in Blood
5866
47162
1.41
75.43
5.9
5.6
e9/l
0.0
0.0
0.63
5018
39879
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4146
31459
1.44
73.25
2.3
2.1
u/l
208.1
224.5
0.49
3833
29253
(3013512) EKG study
3893
29271
1.44
71.98
4.6
4.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3219
23355
1.47
71.76
1.6
1.6
mmol/l
1.3
1.3
0.46
2402
19389
(3019198) Lymphocytes [#/volume] in Blood
5934
48097
1.40
71.21
6.0
5.7
e9/l
1.9
1.9
0.06
5181
41359
(3009542) Hematocrit [Volume Fraction] of Blood
9236
80762
1.44
71.16
20.3
18.5
%
38.7
38.8
0.31
5670
52923
(3026008) Bacteria identified in Urine by Culture
4413
34034
1.42
70.53
3.7
3.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3683
27557
1.44
69.36
2.4
2.3
mg/l
3.0
3.1
1.25
3054
23276
(3000850) Epithelial cells [#/volume] in Urine
3175
23104
1.47
69.28
3.0
2.7
e6/l
4.9
5.4
1.44
2721
20238
(3013650) Neutrophils [#/volume] in Blood by Automated count
6624
54857
1.39
68.93
8.5
8.7
e9/l
4.3
4.3
0.04
5744
47162
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5771
46795
1.39
67.84
2.6
2.5
—
—
—
0
0
(3026782) Osmolality of Urine
2991
21655
1.47
66.54
3.4
2.9
mosm/kgh2o
529.6
546.6
4.65
2562
18412
(3019309) Folate [Moles/volume] in Red Blood Cells
3080
22462
1.46
65.86
1.9
1.8
nmol/l
1202.4
1153.1
1.95
2179
16577
(3015377) Calcium [Moles/volume] in Serum or Plasma
4479
35126
1.39
62.97
3.1
3.4
mmol/l
2.3
2.4
2.18
3755
30085
(3030467) Casts [#/volume] in Urine by Automated count
3913
30181
1.39
60.05
3.7
3.4
e6/l
0.5
0.5
0.06
2996
22989
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
4451
35127
1.38
59.20
5.6
5.3
ug/l
5.2
4.5
0.23
3792
31037
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1409
8939
1.62
56.76
4.7
3.8
mmol/l
1.2
1.2
0.41
1162
7751
(40760892) CBC W Ordered Manual Differential panel - Blood
2594
18808
1.45
55.75
4.9
4.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
3968
30979
1.37
55.53
4.7
4.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
3763
29134
1.38
55.43
3.7
3.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1187
7270
1.67
54.91
4.2
3.9
%
0.6
0.3
0.29
309
1857
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
6538
55194
1.33
54.12
3.2
3.1
u/l
53.4
53.6
0.05
5839
50262
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2522
18406
1.43
51.79
2.0
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1279
8202
1.59
48.86
4.2
3.9
%
0.8
0.9
0.77
359
2403
(3021440) Promyelocytes/100 leukocytes in Blood
1221
7794
1.60
47.50
4.2
3.9
%
0.1
0.1
0.43
337
2240
(3002179) Metamyelocytes/100 leukocytes in Blood
1169
7408
1.61
46.86
3.9
3.7
%
0.5
0.6
0.93
276
1695
(40767503) Oxygen content in Capillary blood by calculation
484
2360
2.06
46.61
2.9
2.5
%
16.0
15.9
0.32
264
1228
(1761868) Lipid panel - Serum or Plasma
3387
26363
1.36
46.49
3.3
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2347
17359
1.40
43.72
2.8
2.5
umol/l
12.3
12.0
1.51
2138
15902
(3026493) Urate [Moles/volume] in Serum or Plasma
3307
25849
1.35
43.61
2.8
2.8
umol/l
3967.0
5787.9
1.79
2706
21831
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2087
15187
1.42
42.55
2.9
2.6
%
22.0
21.2
1.71
1697
12892
(40768797) Stomach Pathology biopsy report
1819
12913
1.45
42.48
1.3
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2192
16140
1.40
41.68
2.8
2.5
g/l
2.3
2.3
0.13
1964
14814
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2234
16539
1.40
41.07
2.0
2.0
s
30.2
30.1
0.31
2160
16040
(40768804) Tissue Pathology biopsy report
4561
37639
1.30
40.00
2.3
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
3505
28064
1.31
38.05
4.8
4.6
%
22.5
22.3
0.34
1735
14687
(3028271) Lactate [Moles/volume] in Capillary blood
370
1764
2.09
37.86
2.1
1.9
mmol/l
1.7
1.7
0.13
364
1724
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2307
17375
1.37
37.84
1.3
1.2
u/ml
1.5
1.8
1.14
582
4359
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1796
12987
1.42
37.50
1.9
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2637
20326
1.35
37.16
1.8
1.7
mg/l
1.4
1.4
0.28
1975
15811
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1897
13929
1.40
36.14
1.3
1.3
iu/ml
38.9
39.6
0.06
579
4351
(3022145) Colonoscopy Study observation
1428
10027
1.45
34.86
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2767
21655
1.33
34.80
4.4
4.1
ng/l
332.4
485.3
1.34
2337
18321
(3012501) Base excess in Blood by calculation
471
2518
1.87
34.68
4.5
4.2
mmol/l
2.6
2.7
0.54
299
1759
(3013290) Carbon dioxide [Partial pressure] in Blood
471
2520
1.87
34.60
4.5
4.2
kpa
4.9
5.0
2.05
462
2449
(3027315) Oxygen [Partial pressure] in Blood
471
2532
1.86
34.08
4.5
4.2
kpa
8.4
8.4
0.06
462
2460
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1772
12999
1.39
33.75
1.9
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5297
45197
1.26
33.50
4.4
4.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
2037
15375
1.36
32.40
1.6
1.5
g/l
2.5
2.6
1.49
1154
8684
(3027945) Reticulocytes/100 erythrocytes in Blood
1809
13409
1.38
32.23
2.6
2.3
%
1.8
1.8
0.25
1552
11665
(3023520) Reticulocytes [#/volume] in Blood
1384
9839
1.43
31.41
2.8
2.5
e9/l
66.9
68.5
0.94
1054
7306
(1616796) Gas panel - Central venous blood
458
2507
1.82
31.29
4.0
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2124
16255
1.34
30.66
27.3
29.0
inr
1.5
1.5
0.13
193
2211
(3006184) Hemoglobin [Mass/volume] in Capillary blood
461
2564
1.80
29.88
2.4
2.2
g/l
127.5
126.8
0.27
376
1848
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
967
6480
1.50
29.71
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2560
20204
1.31
29.60
3.4
3.2
ug/l
0.9
0.8
0.17
1774
14404
(3009508) Creatinine [Moles/volume] in Urine
3764
31196
1.26
29.47
3.3
3.1
mmol/l
7.0
7.1
0.73
2920
25694
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1747
13060
1.36
29.28
1.3
1.2
u/ml
12.4
14.9
0.71
560
4624
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3536
29109
1.27
29.27
3.2
3.2
u/l
33.9
36.5
1.08
3276
27314
(3010421) pH of Blood
504
2911
1.73
28.67
4.4
4.1
ph
7.4
7.4
0.63
464
2450
(3019150) Specific gravity of Urine by Refractometry
2574
20424
1.30
28.42
4.4
4.5
kg/l
1.0
1.0
0.07
392
3362
(3015235) Bicarbonate [Moles/volume] in Capillary blood
505
2945
1.71
27.75
3.0
3.2
mmol/l
24.9
24.9
0.01
457
2576
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
989
6751
1.48
27.69
3.6
3.8
kpa
5.1
5.2
0.67
906
6197
(3009343) pH of Capillary blood
973
6669
1.47
26.65
3.6
3.8
ph
7.4
7.4
0.51
204
866
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
941
6434
1.47
26.09
3.6
3.7
mmol/l
2.3
2.0
1.47
673
4776
(3000034) Microalbumin [Mass/volume] in Urine
206
910
2.24
25.68
3.3
3.0
mg/l
66.6
48.9
0.47
153
668
(3022689) Creatine [Moles/volume] in Urine
88
250
3.48
25.46
1.4
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1129
8033
1.42
25.25
2.0
2.2
nmol/l
375.1
384.7
0.77
1030
7292
(3012516) Albumin [Mass/volume] in Urine
3634
30416
1.24
25.20
3.4
3.2
mg/l
487.0
418.6
0.33
2162
19449
(3007853) Bacteria identified in Skin by Aerobe culture
1533
11519
1.35
24.55
1.9
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
422
2425
1.73
24.47
4.0
3.0
mg/l
1.8
1.7
1.05
376
2185
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2222
17636
1.29
23.97
3.5
3.1
e6/l
3.1
2.7
0.80
1258
9721
(3048689) Calprotectin [Mass/mass] in Stool
1268
9305
1.38
23.57
2.2
2.1
ug/g
142.1
156.2
0.73
948
7237
(3030981) Hyaline casts [#/volume] in Urine by Automated count
829
5653
1.47
23.25
3.4
2.9
e6/l
0.3
0.3
0.63
808
5536
(3005719) IgG [Mass/volume] in Serum or Plasma
927
6480
1.44
22.81
3.3
2.7
g/l
10.4
10.7
0.98
835
5885
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
929
6507
1.43
22.61
6.1
6.5
mmol/l
24.7
24.8
0.35
921
6435
(3020682) Albumin/Creatinine [Ratio] in Urine
3789
32140
1.23
22.61
4.3
3.9
mg/mmol
10.6
10.9
0.10
2225
20278
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
106
365
2.87
22.31
3.1
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1386
10406
1.35
22.19
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
695
4621
1.51
22.08
2.8
2.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1454
11039
1.33
21.55
1.4
1.3
titre
550.5
518.0
0.27
319
2445
(3028626) Oxygen [Partial pressure] in Capillary blood
440
2654
1.65
21.33
2.9
3.2
kpa
7.9
7.9
0.36
411
2460
(3045424) Erythrocytes [Presence] in Urine
279
1480
1.87
21.17
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
379
2205
1.71
21.06
2.7
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
1644
12812
1.30
20.10
1.4
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1384
10535
1.33
20.07
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1112
8206
1.36
19.83
1.6
1.6
—
—
—
0
0
(4034850)
474
2970
1.59
19.70
9.4
11.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
734
5072
1.45
19.19
2.2
1.8
g/l
1.5
1.4
0.17
648
4528
(3044640) Blood type and Crossmatch panel - Blood
3723
31976
1.20
18.74
2.6
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1806
14393
1.27
18.39
2.1
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1070
7953
1.35
18.18
2.4
2.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2114
17184
1.25
18.15
3.3
3.0
mmol/l
0.8
0.8
1.61
1922
15792
(3040151) Glucose [Moles/volume] in Capillary blood
250
1347
1.84
18.13
4.6
13.7
mmol/l
7.5
7.4
0.04
206
1118
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
675
4642
1.45
18.10
2.0
1.9
ug/l
2.7
2.4
0.15
579
4061
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1107
8300
1.34
17.74
3.8
3.7
ng/l
105.8
96.6
1.49
881
6987
(3000012) Reticulocyte production index
148
669
2.19
17.60
1.6
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
2946
24865
1.21
17.60
6.6
6.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
653
4487
1.45
17.59
1.3
1.3
u/ml
157.8
249.4
4.29
592
4095
(3047181) Lactate [Moles/volume] in Blood
495
3222
1.53
17.41
5.1
5.9
mmol/l
1.4
1.3
0.16
425
2833
(3020630) Protein [Mass/volume] in Serum or Plasma
1255
9649
1.31
16.82
2.7
2.5
g/l
65.8
66.0
0.32
1100
8601
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
235
1273
1.83
16.78
1.6
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2499
20835
1.22
16.77
3.0
3.2
mmol/l
2.5
2.5
0.65
2143
17956
(3008152) Bicarbonate [Moles/volume] in Arterial blood
933
6906
1.35
16.25
6.4
6.7
mmol/l
24.5
24.6
0.21
867
6421
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1770
14273
1.25
16.15
6.3
5.4
mmol/l
1.0
1.0
0.15
1612
13020
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1614
12897
1.26
15.91
4.1
3.9
u/l
238.0
248.6
2.98
1526
12063
(3016502) Oxygen saturation in Arterial blood
1456
11497
1.28
15.84
6.6
6.8
%
95.3
95.2
0.07
1390
11026
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1351
10580
1.28
15.70
3.5
3.0
ng/l
230.0
266.7
2.58
1248
9659
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
547
3744
1.46
15.06
2.7
2.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
474
3157
1.49
14.99
1.8
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1434
11413
1.26
14.56
4.8
4.6
%
33.3
33.1
0.31
923
7368
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
779
5715
1.36
14.37
2.5
2.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
978
7434
1.32
14.19
4.3
4.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
3017
25953
1.19
14.13
3.9
4.0
%
84.6
85.1
0.48
2938
25337
(3045414) Leukocytes [Presence] in Urine
600
4230
1.41
14.07
2.1
2.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
673
4850
1.38
13.88
1.3
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1260
9929
1.27
13.87
6.2
6.2
mmol/l
1.3
1.4
0.73
1173
9497
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
936
7099
1.32
13.79
1.8
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1421
11369
1.26
13.76
2.7
2.6
umol/l
8.4
9.5
0.93
1200
9819
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
294
1796
1.62
13.69
4.4
3.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
213
1196
1.76
13.59
1.6
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1213
9542
1.28
13.53
2.2
2.1
g/l
0.2
0.2
0.24
1097
8755
(3003396) Base excess in Arterial blood by calculation
1595
12955
1.24
13.49
6.4
6.5
mmol/l
1.1
1.1
0.14
1251
10060
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
995
7639
1.30
13.41
3.6
2.8
ml/min/173m2
54.0
60.6
7.01
468
3204
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
541
3783
1.42
13.30
3.2
3.1
ratio
2.2
3.7
0.97
44
273
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
554
3895
1.42
13.21
3.3
3.1
mg/l
43.4
50.9
0.47
405
3149
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1303
10379
1.26
13.08
7.2
7.2
g/l
119.8
119.8
0.02
1248
9993
(3039000) Anion gap in Blood
353
2277
1.54
13.04
5.6
6.8
mmol/l
11.4
11.3
0.28
318
2015
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
169
896
1.87
13.04
1.7
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
353
2278
1.54
13.01
5.6
6.8
mmol/l
104.4
105.0
1.29
318
2016
(3017732) Neutrophils [#/volume] in Blood
804
6022
1.33
12.93
3.2
3.1
e9/l
4.1
4.2
0.24
556
4418
(3034860) Kappa light chains.free [Mass/volume] in Serum
553
3904
1.41
12.89
3.3
3.1
mg/l
65.8
81.9
0.40
404
3155
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
242
1436
1.67
12.67
1.6
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1584
12974
1.23
12.32
6.5
6.5
kpa
11.8
11.9
0.29
1499
12228
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1584
12982
1.23
12.24
6.5
6.5
kpa
5.0
5.1
2.13
1497
12243
(3015171) Extractable nuclear Ab [Units/volume] in Serum
447
3067
1.45
12.21
1.3
1.2
u/ml
1.3
1.0
0.20
42
273
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
352
2310
1.51
12.03
1.7
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
765
5760
1.32
11.87
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
824
6272
1.31
11.83
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
423
2897
1.45
11.69
3.5
3.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
256
1574
1.61
11.68
3.2
2.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1257
10114
1.25
11.51
7.7
6.5
mmol/l
11.4
11.2
0.43
1160
9507
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
117
573
2.02
11.46
4.4
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
244
1504
1.61
11.05
1.7
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
776
5925
1.31
10.90
2.2
2.1
nmol/l
12.0
11.6
0.64
634
5105
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
291
1880
1.53
10.75
1.1
1.1
u/ml
6.7
9.5
0.30
18
164
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
278
1779
1.55
10.73
1.7
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
582
4282
1.35
10.59
1.4
1.5
u/ml
23.5
18.3
0.18
12
105
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
356
2413
1.46
10.43
1.6
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
368
2513
1.45
10.37
1.7
1.5
g/l
0.2
0.2
0.44
348
2363
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
375
2588
1.44
10.00
1.7
1.5
g/l
1.2
1.2
0.49
356
2437
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
299
1978
1.50
9.91
1.3
1.3
mg/l
558.1
535.6
0.11
291
1859
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
209
1279
1.62
9.80
2.3
2.1
mg/l
23.8
27.0
0.32
48
329
(3042111) Morphology [Interpretation] in Bone marrow Narrative
284
1870
1.50
9.65
1.5
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
236
1498
1.56
9.50
1.5
1.4
u/l
10.8
11.5
0.34
185
1220
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
754
5844
1.28
9.47
8.7
8.9
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
143
811
1.74
8.98
1.5
1.3
g/l
0.4
0.4
1.66
92
560
(3028192) IgG subclass 2 [Mass/volume] in Serum
143
811
1.74
8.98
1.5
1.3
g/l
2.7
3.0
0.93
92
557
(3027135) IgG subclass 1 [Mass/volume] in Serum
143
811
1.74
8.98
1.5
1.3
g/l
5.9
7.1
4.50
93
558
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
200
1240
1.59
8.93
1.4
1.6
%
59.0
61.4
0.33
121
762
(3003327) Ova and parasites identified in Stool by Light microscopy
358
2516
1.41
8.69
1.7
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
205
1293
1.57
8.53
1.7
1.6
g/l
0.7
0.8
1.50
141
964
(4062490)
141
809
1.72
8.53
1.5
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
244
1602
1.51
8.46
1.3
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
259
1737
1.47
8.11
1.3
1.4
e6/l
33.8
21.4
0.31
210
1350
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
95
491
1.91
8.11
1.1
1.2
mg/l
35.6
43.5
1.39
83
410
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
35
117
2.95
8.01
2.7
2.5
mg/l
116.5
61.9
—
9
19
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
90
459
1.93
8.00
1.1
1.1
mg/l
248.8
297.9
1.92
78
402
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
258
1738
1.47
7.91
1.4
1.4
e6/l
1321.0
1112.7
0.11
224
1416
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
112
618
1.79
7.79
1.8
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
445
3301
1.34
7.76
1.1
1.1
u/ml
1.0
1.6
—
6
50
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1032
8483
1.21
7.68
1.6
1.6
—
—
—
0
0
(3019225) pH of Specimen
1217
10169
1.19
7.60
3.9
4.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
341
2435
1.39
7.59
1.9
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
368
2661
1.37
7.59
1.7
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
298
2081
1.42
7.56
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
195
1253
1.54
7.53
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
105
577
1.79
7.43
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
607
4726
1.28
7.41
3.8
3.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
111
621
1.76
7.40
1.8
1.5
—
—
—
0
0
(3020891) Body temperature
550
4249
1.28
7.16
5.5
4.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
650
5131
1.26
7.09
3.3
3.2
pmol/l
4.4
4.4
0.03
562
4476
(3017315) Amylase [Enzymatic activity/volume] in Urine
90
479
1.85
7.08
1.2
1.2
u/l
291.8
332.2
0.13
85
441
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
575
4477
1.27
7.04
4.4
5.0
%
1.8
1.6
2.01
536
4182
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
456
3447
1.31
7.01
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
253
1742
1.44
6.97
1.6
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
212
1415
1.48
6.88
1.6
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
25
75
3.28
6.87
1.0
1.3
pmol/l
12.8
21.2
0.59
20
69
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2715
24240
1.13
6.87
2.5
2.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
147
910
1.59
6.73
1.4
1.3
—
34.0
—
0
8
(3027456) Digoxin [Moles/volume] in Serum or Plasma
393
2929
1.33
6.69
3.5
3.2
nmol/l
0.8
0.8
1.98
315
2283
(3037756) Immunofixation for Serum or Plasma
350
2566
1.35
6.66
1.6
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
565
4422
1.27
6.65
4.5
5.0
%
0.9
0.9
1.51
522
4134
(3000570) Elastase.pancreatic [Mass/mass] in Stool
388
2893
1.33
6.60
1.5
1.4
ug/g
275.8
265.4
0.44
223
1744
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
250
1737
1.42
6.58
1.3
1.3
mmol/l
3.9
3.9
0.11
242
1616
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
509
3940
1.28
6.55
4.0
4.2
mmol/l
25.0
24.9
0.41
456
3568
(3011397) Hemoglobin [Presence] in Urine by Test strip
2575
22979
1.13
6.53
4.0
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
558
4374
1.27
6.49
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
472
3624
1.29
6.48
1.9
1.8
u/l
38.9
39.1
0.06
409
3077
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
135
830
1.60
6.38
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
199
1338
1.47
6.26
2.4
2.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
83
449
1.82
6.26
1.1
1.1
—
—
—
0
0
(4027681)
68
346
1.94
6.19
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
117
700
1.65
6.18
2.6
2.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
223
1539
1.43
6.13
1.6
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
133
824
1.59
6.11
1.9
1.8
mg/l
4.8
4.5
0.20
122
767
(4035726)
1067
8997
1.18
6.01
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2115
18743
1.13
5.98
3.2
2.9
e6/l
1.0
1.4
1.20
1153
10758
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
107
638
1.65
5.76
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
957
8055
1.18
5.53
1.6
1.5
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
48
225
2.10
5.51
1.3
1.3
%
24.0
28.4
—
5
33
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
431
3346
1.28
5.49
1.8
1.6
titre
168.3
318.1
1.79
29
144
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
359
2723
1.30
5.47
1.4
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
40
175
2.25
5.44
2.5
2.0
e6/l
3016.7
1201.0
0.29
27
89
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
503
3992
1.25
5.32
2.7
2.3
g/l
1.2
1.0
0.47
403
3357
(40761535) Cells panel - Urine sediment
995
8430
1.17
5.31
3.4
3.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
686
5628
1.21
5.28
1.8
1.6
g/l
1.5
1.6
1.30
568
4788
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
83
477
1.71
5.17
2.1
2.0
nmol/l
17.0
16.5
0.17
76
444
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
190
1317
1.42
5.17
2.2
2.4
u/ml
463.3
2198.5
1.49
11
85
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
47
225
2.06
5.13
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
47
225
2.06
5.13
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
47
225
2.06
5.13
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
47
225
2.06
5.13
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
82
471
1.72
5.12
1.8
2.2
ml
1875.2
1830.7
0.14
70
395
(3014576) Chloride [Moles/volume] in Serum or Plasma
1584
13922
1.13
5.08
7.0
6.5
mmol/l
104.3
104.3
0.00
1528
13603
(3003181) Sodium [Moles/volume] in Urine
279
2069
1.33
5.03
1.6
1.3
mmol/l
62.3
62.0
0.05
226
1656
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
108
671
1.59
4.99
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
113
714
1.56
4.87
1.7
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
431
3398
1.26
4.87
1.1
1.1
titre
318.1
206.2
—
8
72
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
255
1876
1.34
4.87
1.3
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
193
1358
1.40
4.85
1.6
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
103
638
1.59
4.83
2.4
2.1
min
477.9
499.5
1.04
66
466
(3016018) Differential panel - Cerebral spinal fluid
127
826
1.52
4.81
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
470
3753
1.24
4.75
1.1
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
28
4.21
4.70
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
101
1525
0.65
4.56
2.3
2.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
103
1546
0.65
4.53
2.3
2.5
mmol/l
4.1
4.1
0.12
103
1532
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
96
595
1.59
4.52
2.0
2.1
u/field
2.3
2.4
0.03
56
406
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
290
2200
1.30
4.49
1.7
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
571
4682
1.21
4.47
2.5
2.2
g/l
7.3
7.5
1.98
387
3462
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
138
929
1.46
4.45
1.3
1.2
mmol/l
8.4
7.6
1.43
107
651
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
569
4667
1.21
4.44
2.5
2.2
g/l
3.8
3.8
0.33
373
3337
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
57
308
1.82
4.43
6.6
4.8
%
68.5
72.9
0.60
48
250
(3008898) HLA-B27 [Presence]
259
1942
1.32
4.38
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
51
267
1.88
4.38
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2605
23721
1.10
4.37
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
569
4677
1.20
4.35
2.5
2.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
149
1024
1.44
4.32
1.4
1.3
mosm/kgh2o
277.1
277.0
0.00
115
766
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
136
920
1.46
4.29
1.8
1.6
u/ml
25.3
24.6
0.07
27
206
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1065
9223
1.15
4.28
1.6
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
13
35
3.65
4.24
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
230
1709
1.33
4.17
1.3
1.2
u/ml
7.6
3.0
0.62
18
129
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
58
322
1.77
4.15
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
93
587
1.56
4.09
7.9
11.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
23
90
2.51
4.06
1.3
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
331
2591
1.26
4.04
1.7
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
7876
75155
1.08
4.04
24.7
22.2
g/l
331.3
331.2
0.78
7825
74239
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
143
992
1.42
3.98
1.3
1.3
u/l
13.9
13.5
0.09
125
914
(3034891) Synovial lining cells/100 cells in Synovial fluid
78
477
1.61
3.94
1.3
1.5
%
14.0
3.5
—
7
115
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
35
167
2.06
3.93
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
283
2182
1.28
3.93
1.2
1.2
titre
136.9
163.9
0.19
26
180
(46235355) HIV 1 and 2 tests - Meaningful Use set
1210
10632
1.13
3.92
1.7
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
285
2202
1.28
3.89
1.3
1.2
u/ml
56.3
45.9
0.20
20
123
(3004809) Band form neutrophils/100 leukocytes in Blood
230
1728
1.31
3.88
3.8
3.5
%
1.3
1.5
0.35
192
1303
(1175426) CD3 cells/100 lymphocytes in Blood
95
611
1.53
3.87
2.1
2.0
%
69.7
70.8
0.22
88
576
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
83
518
1.58
3.86
1.4
1.3
u/ml
1.5
1.4
0.06
49
255
(3021879) Hepatitis B virus core Ab [Presence] in Serum
625
5245
1.18
3.83
1.3
1.3
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
15
48
3.07
3.80
1.1
1.2
ng/l
2285.3
2977.9
—
9
31
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
133
919
1.43
3.80
1.5
1.4
u/l
14.3
13.2
1.13
125
882
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
529
4380
1.19
3.79
2.4
2.3
g/l
3.0
3.1
2.09
377
3389
(3019977) pH of Arterial blood
103
678
1.50
3.78
2.9
2.4
ph
7.4
7.4
0.06
42
242
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
117
791
1.46
3.76
1.1
1.1
—
4.5
—
0
9
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
91
584
1.54
3.76
2.2
2.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
251
1918
1.29
3.75
1.4
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
226
1705
1.31
3.72
5.0
4.6
iu/ml
1024.0
2137.4
0.47
36
246
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
80
500
1.58
3.71
1.2
1.1
u/l
30.2
32.5
0.11
61
360
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
300
2350
1.26
3.68
1.3
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
267
2063
1.28
3.67
1.3
1.2
u/ml
7.7
6.1
0.29
44
326
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
52
291
1.76
3.67
1.0
1.0
u/ml
1.3
6.6
—
5
44
(40761539) Cells [Type] in Urine sediment by Light microscopy
49
270
1.79
3.64
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
495
4095
1.20
3.60
1.8
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
89
575
1.52
3.58
2.0
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
132
922
1.41
3.58
1.3
1.6
%
31.2
29.0
0.25
73
564
(3023183) Ammonium ion [Moles/volume] in Plasma
272
2114
1.27
3.58
2.3
2.4
umol/l
30.5
33.9
1.68
217
1733
(3008037) Lactate [Moles/volume] in Venous blood
205
2621
0.76
3.57
2.7
3.4
mmol/l
1.6
1.6
0.11
199
2565
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
81
515
1.55
3.51
2.5
2.3
e6/l
482.6
508.2
0.19
66
424
(21494434) Karyotype in Bone marrow
132
926
1.41
3.50
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
216
1638
1.30
3.46
1.8
1.7
mu/l
322.2
299.6
0.57
199
1491
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
91
596
1.50
3.45
2.2
2.0
%
15.2
14.6
0.11
45
239
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
79
502
1.55
3.44
1.2
1.1
u/l
104.2
94.1
0.23
65
373
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
314
2495
1.24
3.43
1.7
1.6
iu/ml
0.4
6.4
1.47
67
610
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
78
495
1.55
3.42
1.1
1.1
nmol/l
4.5
10.0
0.82
21
104
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
57
335
1.68
3.41
2.4
2.7
umol/l
26.1
28.8
1.22
43
249
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
59
350
1.66
3.41
1.1
1.1
u/l
1.1
1.1
0.23
25
167
(3044242) Glucose [Moles/volume] in Arterial blood
92
606
1.50
3.40
1.9
1.9
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
52
299
1.71
3.37
1.3
1.3
%
24.7
21.8
0.28
40
246
(3043410) Blood group antigens tested for on Red Blood Cells
49
277
1.74
3.37
1.9
1.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
24
106
2.23
3.31
1.3
1.2
mmol/l
5.9
6.4
0.23
11
49
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
334
2685
1.23
3.29
2.5
2.4
g/l
3.6
3.6
0.38
316
2540
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
474
3943
1.19
3.27
2.1
2.3
ug/l
428.9
611.0
1.29
439
3704
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
261
2043
1.26
3.27
1.3
1.2
u/ml
19.0
4.3
0.72
29
213
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
234
1808
1.28
3.26
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
192
1446
1.31
3.26
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
160
1174
1.34
3.25
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
187
1404
1.31
3.24
1.1
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
76
489
1.53
3.16
2.7
2.3
e9/l
0.2
0.2
0.03
65
423
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
166
1231
1.33
3.15
1.3
1.3
nmol/l
0.6
3.0
1.12
157
1172
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1317
11781
1.11
3.15
3.6
3.9
ug/l
9.7
25.2
5.13
1052
9753
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
325
2620
1.22
3.14
2.6
2.3
ug/min
134.4
103.3
0.58
198
1556
(3011412) CD3 cells [#/volume] in Blood
112
781
1.41
3.12
2.5
2.2
e9/l
1.1
1.1
0.04
71
490
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
529
4464
1.17
3.10
2.0
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
112
782
1.41
3.10
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
249
3048
0.80
3.09
4.5
4.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
424
3513
1.19
3.08
2.6
2.2
g/l
0.0
0.0
0.68
378
3155
(3042733) HLA Ab [Presence] in Serum
37
198
1.84
3.07
5.6
4.9
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
54
323
1.65
3.06
1.3
1.2
g/l
43.7
38.3
1.60
26
166
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
70
446
1.55
3.06
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
375
3075
1.20
3.06
1.6
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
84
557
1.49
3.05
1.6
1.9
umol/l
14.5
7.8
0.61
59
407
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
96
655
1.44
3.02
1.4
1.4
nmol/l
0.2
0.3
1.09
66
489
(3010375) cycloSPORINE [Mass/volume] in Blood
54
325
1.64
2.99
27.7
25.7
ug/l
106.3
106.2
0.00
47
270
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
76
496
1.51
2.99
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
102
707
1.42
2.96
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
275
2201
1.23
2.88
1.2
1.2
titre
1152.5
855.9
—
8
75
(3014051) Protein [Presence] in Urine by Test strip
291
2344
1.23
2.87
2.7
2.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
441
3694
1.18
2.86
2.3
2.1
g/l
37.5
36.9
1.26
356
3103
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
461
3877
1.17
2.85
1.9
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
76
502
1.49
2.84
1.1
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
21
94
2.20
2.84
1.1
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
105
738
1.40
2.83
1.7
1.2
mmol/l
34.0
35.1
0.22
89
605
(4010399)
748
6519
1.14
2.83
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
509
4317
1.17
2.83
1.9
1.9
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
164
1237
1.31
2.81
1.3
1.3
nmol/l
0.3
0.3
—
5
97
(3039162) Centromere protein B Ab [Units/volume] in Serum
134
982
1.34
2.80
1.2
1.2
u/ml
15.3
45.8
—
6
73
(3051101) Glucose [Moles/volume] in Cord blood
9
230
0.38
2.78
3.6
6.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
515
4385
1.16
2.73
2.4
2.2
g/l
10.3
10.4
0.17
413
3629
(3011985) Renin [Units/volume] in Plasma
156
1174
1.31
2.73
1.5
1.4
mu/l
45.8
68.6
1.20
137
1038
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
39
221
1.74
2.72
1.1
1.1
%
89.5
86.6
0.35
17
106
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
112
802
1.38
2.72
1.2
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
109
2.08
2.71
1.3
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
549
4705
1.15
2.67
1.2
1.2
iu/ml
163.3
137.0
0.37
184
1634
(44790048)
138
1024
1.33
2.67
1.6
1.4
—
—
—
0
0
(44790047)
138
1024
1.33
2.67
1.6
1.4
—
—
—
0
0
(44806118)
138
1024
1.33
2.67
1.6
1.4
—
—
—
0
0
(44790049)
138
1024
1.33
2.67
1.6
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
340
2803
1.20
2.67
1.4
1.4
iu/ml
12.5
16.0
—
7
65
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
90
625
1.42
2.62
1.2
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
13
48
2.66
2.62
1.4
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
9
24
3.69
2.62
1.4
1.4
nmol/l
407.7
609.0
—
9
24
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
198
1548
1.26
2.59
1.3
1.2
u/ml
34.4
50.8
0.62
14
160
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
284
2311
1.21
2.57
2.0
1.8
mg/l
11.6
11.8
0.18
260
2123
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
164
1254
1.29
2.57
1.3
1.3
u/l
435.2
479.9
0.15
156
1181
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
10
32
3.07
2.56
1.0
1.1
nmol/l
424.2
253.7
—
10
32
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
17
73
2.29
2.54
2.1
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
208
1640
1.25
2.54
1.2
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
38
219
1.71
2.52
1.1
1.2
%
112.1
103.3
0.77
30
205
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
5
7
7.02
2.52
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
225
1795
1.24
2.48
2.5
2.6
%
62.8
62.1
0.19
225
1785
(3023420) DNA double strand Ab [Units/volume] in Serum
119
875
1.34
2.48
1.6
1.4
iu/ml
45.8
26.7
—
9
36
(3045716) Anion gap in Serum or Plasma
77
526
1.44
2.47
2.5
2.1
mmol/l
8.8
9.1
0.35
57
413
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
34
191
1.75
2.47
1.2
1.3
mg/l
0.9
37.1
0.72
25
138
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
271
2206
1.21
2.46
2.9
3.2
u/ml
303.4
782.3
1.49
234
2010
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
63
414
1.50
2.46
2.2
2.1
%
102.4
94.7
0.89
54
391
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
16
68
2.31
2.45
1.3
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
217
1727
1.24
2.45
1.8
1.7
nmol/l
44.0
44.2
0.05
207
1661
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
31
170
1.79
2.44
1.3
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
141
1065
1.30
2.44
1.3
1.3
nmol/l
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
145
1100
1.30
2.43
1.4
1.3
pmol/l
245.7
299.4
0.91
106
831
(3011325) HIV 1+2 Ab [Presence] in Serum
9
26
3.40
2.43
1.1
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
56
361
1.53
2.40
2.8
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
56
361
1.53
2.40
2.8
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
108
787
1.35
2.40
1.1
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
47
291
1.59
2.39
28.3
32.1
ug/l
6.9
7.3
0.78
42
258
(3027923) C peptide [Moles/volume] in Serum or Plasma
70
473
1.46
2.39
1.5
1.3
nmol/l
1.2
1.2
0.02
56
362
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
95
2.07
2.37
1.0
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
698
6132
1.13
2.37
8.2
8.0
mmol/l
24.4
24.4
0.02
632
5641
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
37
217
1.68
2.33
1.0
1.2
%
94.9
87.0
1.03
17
109
(3017569) Oxygen content in Arterial blood
84
591
1.40
2.32
2.4
2.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
20
96
2.05
2.32
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
46
286
1.58
2.31
1.2
1.2
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
30
166
1.78
2.31
1.4
1.2
mmol/l
0.4
1.6
1.83
18
106
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
149
1144
1.28
2.30
1.3
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
37
218
1.67
2.30
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
136
1034
1.30
2.27
1.4
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
39
234
1.64
2.26
1.7
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
233
1890
1.22
2.23
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
233
1890
1.22
2.23
1.3
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
8
23
3.42
2.22
1.1
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
76
530
1.41
2.22
5.7
6.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
55
360
1.50
2.22
7.5
6.6
mmol/l
24.2
25.1
0.89
50
319
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
59
392
1.48
2.22
1.1
1.2
ratio
1.1
1.1
0.01
20
129
(3017704) Immunofixation for Urine
89
638
1.37
2.22
1.6
1.5
—
—
—
0
0
(3012544) pH of Venous blood
1220
11074
1.09
2.22
3.9
3.8
ph
7.4
7.4
—
9
48
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
184
1457
1.24
2.21
5.6
6.2
mg/l
11.7
12.2
0.90
168
1291
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
161
1256
1.26
2.20
2.2
2.1
u/l
2886.7
4529.7
0.54
45
485
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
99
723
1.35
2.20
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
91
656
1.37
2.19
2.3
2.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
382
4331
0.86
2.16
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
154
1199
1.27
2.15
1.3
1.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
24
3.28
2.13
1.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
158
1237
1.26
2.11
1.3
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
70
486
1.42
2.11
1.3
1.4
%
69.2
64.1
0.63
56
391
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
88
636
1.36
2.10
1.3
1.2
mmol/l
11.6
11.8
0.06
24
186
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
154
1203
1.26
2.10
1.3
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
149
1160
1.27
2.09
3.3
3.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
154
1204
1.26
2.09
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
154
1204
1.26
2.09
1.3
1.4
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
38
232
1.61
2.09
1.2
1.3
nmol/l
232.8
151.2
0.47
26
161
(44816559) Phosphatidylethanol [Mass/volume] in Blood
157
1231
1.26
2.08
1.3
1.3
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
14
61
2.26
2.06
1.1
1.1
u/field
1.3
1.1
—
9
35
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
102
757
1.33
2.06
1.6
1.3
titre
41.8
69.4
0.75
11
65
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
105
783
1.32
2.05
1.6
1.3
titre
242.0
393.5
0.47
15
79
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
97
715
1.34
2.05
4.9
4.9
u/ml
117.2
117.4
0.00
29
204
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
636
5612
1.12
2.05
4.1
4.0
mmol/l
24.2
24.1
0.08
559
5056
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1054
9545
1.09
2.04
2.6
2.4
u/l
35.4
52.6
1.20
873
8098
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
125
956
1.29
2.03
1.4
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
157
1235
1.25
2.03
1.4
1.4
mmol/l
6.5
6.4
0.18
148
1128
(3025018) Bordetella pertussis Ab [Titer] in Serum
55
368
1.47
2.03
1.3
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
42
265
1.56
2.02
1.8
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
295
2473
1.18
2.00
1.6
1.6
e6/l
13447.2
14850.2
0.30
230
1738
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
99
737
1.32
1.97
1.3
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
18
89
1.99
1.96
1.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
154
1215
1.25
1.95
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
211
1722
1.21
1.94
1.6
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
213
1740
1.21
1.94
1.2
1.3
u/l
51.8
37.4
0.44
184
1499
(3008116) Ketones [Moles/volume] in Urine by Test strip
32
191
1.65
1.94
1.3
1.3
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
5
11
4.47
1.91
1.2
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
8
27
2.91
1.89
1.1
1.3
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
9
33
2.68
1.88
1.6
1.5
mg/l
0.8
2.8
—
9
23
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
9
33
2.68
1.88
1.6
1.5
mg/l
2.3
1.6
—
9
23
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
168
1346
1.23
1.87
1.5
1.4
u/ml
114.2
124.3
0.57
45
289
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
55
375
1.44
1.87
1.2
1.3
ug/l
97.4
242.0
0.63
25
215
(3024928) Oxygen saturation in Venous blood
281
2363
1.17
1.86
2.8
2.9
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
11
45
2.40
1.86
1.0
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
91
676
1.33
1.86
2.2
2.1
%
37.9
38.5
0.04
13
77
(3047007) Chlamydophila sp Ab [Presence] in Serum
119
917
1.28
1.85
1.3
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
10
39
2.52
1.85
1.3
1.1
—
—
—
0
0
(4211845)
70
501
1.38
1.82
6.7
3.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
188
1529
1.21
1.82
1.5
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
450
3924
1.13
1.80
4.2
3.8
mmol/l
1.4
1.4
0.16
442
3846
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
143
1131
1.25
1.80
1.2
1.2
u/ml
2.2
4.6
1.94
52
369
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
28
165
1.67
1.79
1.5
3.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
12
4.10
1.79
1.2
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
27
158
1.68
1.78
1.3
1.2
umol/l
17.0
17.0
0.01
22
147
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
13
59
2.17
1.76
3.2
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
750
6737
1.10
1.76
3.3
3.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
54
372
1.43
1.75
1.5
1.9
umol/l
98.7
118.9
0.21
24
202
(3004119) Hemoglobin [Mass/volume] in Venous blood
738
6630
1.10
1.74
3.5
3.3
g/l
126.2
126.9
0.41
717
6476
(3020874) Milk IgE Ab [Units/volume] in Serum
44
292
1.48
1.73
1.0
1.1
u/ml
1.6
1.9
0.07
18
91
(3028679) Herpes simplex virus Ab [Presence] in Serum
48
325
1.45
1.71
1.1
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
74
541
1.35
1.70
2.7
2.3
e6/l
649.9
587.3
0.42
27
216
(3044009) aPTT.lupus sensitive (LA screen)
13
60
2.13
1.70
1.1
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
22
123
1.76
1.70
1.5
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
39
568
0.67
1.70
1.4
1.5
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
26
153
1.67
1.69
1.5
1.2
u/l
79.4
493.9
0.73
17
108
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
257
2166
1.17
1.69
1.8
1.9
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
5
13
3.78
1.68
1.6
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
45
302
1.47
1.68
1.8
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
140
1115
1.24
1.68
1.2
1.2
u/l
54.8
62.2
1.06
99
751
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
41
270
1.49
1.68
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
497
4383
1.12
1.67
3.1
2.8
u/ml
0.3
0.3
0.89
283
2470
(3047352) Trisomy 18 risk [Likelihood] in Fetus
38
554
0.67
1.67
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
1041
9515
1.08
1.66
8.3
7.4
—
—
—
0
0
(4015189)
39
255
1.50
1.65
2.1
2.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
87
655
1.31
1.65
1.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
312
2675
1.15
1.64
2.3
2.2
%
89.8
89.1
0.22
291
2517
(3014271) Vancomycin [Susceptibility]
90
682
1.30
1.63
2.8
3.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
38
551
0.68
1.63
1.4
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
64
461
1.37
1.63
7.2
3.6
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
19
3.10
1.63
1.0
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
766
6919
1.09
1.62
8.8
8.1
%
93.9
93.7
0.33
759
6891
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
392
4331
0.89
1.59
3.1
3.8
u/ml
75.9
74.6
0.02
374
4149
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
291
2490
1.15
1.59
2.0
2.4
%
200.0
203.9
0.31
273
2347
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
769
6957
1.09
1.58
8.7
8.0
%
0.7
0.7
0.56
761
6899
(21491868) Cryoglobulin [Mass/volume] in Serum
47
323
1.43
1.57
1.4
1.2
g/l
0.3
0.2
—
6
21
(3000492) Spirometry study
837
7607
1.09
1.55
1.4
1.5
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
20
2.95
1.55
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
91
697
1.29
1.54
1.2
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
56
2.11
1.54
1.8
2.3
—
—
—
0
0
(4094501)
277
2368
1.15
1.54
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
268
2287
1.15
1.53
3.6
3.7
mg/l
30.0
29.5
0.08
174
1531
(3036525) Urea [Moles/time] in 24 hour Urine
13
63
2.03
1.53
3.8
3.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
63
2.03
1.53
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
29
181
1.58
1.52
1.1
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
14
70
1.97
1.52
1.1
1.1
u/ml
0.0
0.7
—
5
46
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
238
2015
1.16
1.51
1.6
1.7
iu/l
3.8
4.5
0.82
74
637
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
62
451
1.35
1.51
1.1
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
379
3314
1.13
1.51
2.5
2.2
g/l
0.0
0.0
0.62
337
2968
(3019420) Tryptase [Mass/volume] in Serum or Plasma
49
343
1.41
1.50
1.4
1.7
ug/l
8.4
10.3
0.40
42
307
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
59
427
1.36
1.49
1.1
1.1
iu/ml
20.7
9.9
—
9
105
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
27
2.55
1.48
1.1
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
127
1020
1.23
1.45
2.3
2.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
137
1109
1.22
1.45
1.2
1.2
u/ml
3.2
4.0
0.61
60
482
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
34
223
1.50
1.45
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
516
5580
0.90
1.45
3.7
3.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
32
208
1.51
1.43
1.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
372
3264
1.12
1.42
2.5
2.2
g/l
0.0
0.0
0.00
337
2958
(3036489) Thrombin time
395
3479
1.12
1.41
1.7
1.9
s
21.8
22.0
0.30
346
3101
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
38
257
1.45
1.41
1.4
1.2
g/l
0.3
0.3
0.04
30
207
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
19
309
0.60
1.41
14.3
11.2
nmol/l
914.5
830.3
0.27
19
294
(3024891) Influenza virus A+B Ag [Presence] in Specimen
291
2516
1.14
1.40
1.2
1.2
—
—
—
0
0
(4268621)
96
751
1.26
1.40
2.3
2.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
767
6981
1.08
1.40
8.7
7.9
%
1.3
1.4
0.90
760
6925
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
57
415
1.35
1.40
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1109
10237
1.07
1.40
1.4
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
151
1240
1.20
1.39
2.0
1.8
pmol/l
188.8
196.7
0.45
146
1144
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
63
467
1.33
1.38
1.2
1.2
—
—
—
0
0
(4146454)
139
1134
1.21
1.38
2.4
2.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
142
1161
1.20
1.38
3.3
3.5
nmol/l
8.8
13.2
0.28
137
1131
(3046861) Legionella sp Ag [Presence] in Urine
12
59
2.00
1.37
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
130
1056
1.21
1.35
1.1
1.1
g/l
1.5
1.5
1.30
112
951
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
120
967
1.22
1.35
1.1
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
39
268
1.43
1.34
1.3
1.4
iu/ml
—
1308639.3
—
0
14
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
559
5029
1.10
1.34
3.2
2.7
%
0.7
0.7
0.04
536
4839
(3004775) Volume in Urine collected for unspecified duration
112
897
1.23
1.34
2.5
2.2
ml
699.8
637.8
0.76
71
602
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
166
1381
1.18
1.34
1.3
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
91
713
1.26
1.33
1.5
1.3
u/l
25.2
30.8
0.82
76
579
(3048879) Bone marrow aspiration report
46
327
1.38
1.32
1.5
1.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
96
1.74
1.31
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
17
96
1.74
1.31
1.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
88
688
1.26
1.31
1.3
1.2
u/ml
71.3
32.3
—
7
53
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
57
421
1.33
1.30
1.3
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
100
796
1.24
1.28
1.3
1.3
nmol/l
1.4
1.4
0.01
90
716
(3023511) Choriogonadotropin [Units/volume] in Urine
75
577
1.28
1.28
1.5
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
27
174
1.53
1.28
1.6
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
30
198
1.49
1.27
2.1
1.7
mmol/l
1.2
1.2
0.49
30
189
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
34
2.31
1.27
1.1
2.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1158
10746
1.06
1.26
4.0
3.8
kpa
5.8
5.8
0.19
1112
10396
(3020191) Ethanol [Moles/volume] in Serum or Plasma
79
613
1.27
1.26
1.5
1.4
promille
1.1
1.2
0.25
58
466
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
18
2.73
1.26
1.8
2.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
399
3544
1.11
1.26
3.0
3.0
g/l
0.4
0.3
0.45
167
1481
(21494890) Protein electrophoresis panel - 24 hour Urine
146
1212
1.19
1.23
2.0
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
90
712
1.24
1.23
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
40
282
1.40
1.22
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
12
62
1.90
1.21
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
81
634
1.26
1.21
1.3
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
25
2.36
1.21
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
56
418
1.32
1.20
1.3
1.4
%
2.8
2.8
0.00
51
342
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
48
350
1.35
1.20
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
155
1297
1.18
1.20
1.3
1.2
u/ml
281.2
288.6
0.13
91
800
(3023323) Follitropin [Units/volume] in Serum or Plasma
228
1965
1.14
1.20
1.4
1.4
iu/l
27.8
32.2
1.31
197
1677
(3010144) Erythrocytes [#/volume] in Synovial fluid
117
956
1.20
1.18
1.2
1.4
e6/l
202152.3
153050.9
0.22
72
644
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
322
2839
1.12
1.18
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
49
360
1.34
1.18
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
322
2840
1.12
1.17
1.3
1.3
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
28
186
1.48
1.17
1.4
1.4
%
16.7
22.0
0.39
21
141
(3019832) Treponema pallidum Ab [Presence] in Serum
437
3922
1.10
1.15
1.5
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
372
3313
1.11
1.14
4.4
4.1
mmol/l
3.9
3.9
0.13
334
3077
(3041918) Cholesterol [Moles/volume] in Pleural fluid
33
228
1.42
1.14
1.4
1.2
mmol/l
1.8
1.6
0.70
21
141
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
39
2.02
1.13
1.5
1.5
—
—
—
0
0
(4306422)
129
1070
1.19
1.12
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
65
501
1.28
1.12
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
450
4820
0.91
1.10
1.8
1.8
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
37
263
1.38
1.10
1.1
1.3
%
36.7
32.0
0.27
23
166
(3012494) Peanut IgE Ab [Units/volume] in Serum
23
149
1.52
1.09
1.0
1.1
u/ml
1.4
1.3
—
9
70
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
74
583
1.25
1.08
1.5
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
74
583
1.25
1.08
1.5
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
237
2066
1.13
1.08
1.6
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
18
111
1.59
1.05
1.1
1.1
mg/g
7.3
9.2
0.46
18
106
(3023410) Appearance of Cerebral spinal fluid
97
790
1.21
1.05
1.5
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
219
1904
1.13
1.04
1.4
1.5
g/l
32.0
31.6
0.14
191
1671
(44813793)
61
472
1.27
1.04
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
21
135
1.53
1.04
1.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
9
46
1.92
1.02
1.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
44
327
1.32
1.01
1.2
1.1
ng/l
1383.8
537.2
0.49
12
86
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
124
1037
1.18
1.01
1.1
1.1
%
121.5
115.7
1.03
106
914
(3001556) Androgen free Index in Serum or Plasma
7
34
2.02
1.01
1.3
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
30
210
1.40
0.99
1.0
1.1
umol/24h
0.7
0.6
0.38
15
93
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
74
591
1.23
0.98
2.1
2.2
ug/min
133.4
159.1
0.11
16
146
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
59
459
1.26
0.98
1.1
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
35
1.97
0.98
1.9
2.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
30
211
1.40
0.97
1.4
1.5
%
9.0
10.2
0.15
20
111
(3024869) Neuronal Ab [Presence] in Serum
26
178
1.44
0.97
1.2
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
59
460
1.26
0.96
2.4
2.6
%
42.6
36.2
1.02
22
162
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
59
460
1.26
0.96
1.1
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
853
7925
1.06
0.95
1.6
1.7
%
1.5
1.5
0.32
727
6714
(4281824)
90
1058
0.83
0.95
1.1
1.2
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
11
61
1.77
0.93
7.3
2.9
pmol/l
32.8
98.8
—
5
21
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
20
288
0.68
0.93
1.2
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
139
0.57
0.93
3.1
2.3
—
—
—
0
0
(1002224) Polysomnography panel
280
2492
1.11
0.92
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
81
659
1.21
0.91
2.3
1.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
39
290
1.32
0.91
1.1
1.1
%
95.4
94.2
0.07
29
218
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
155
1332
1.15
0.91
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
390
3530
1.09
0.91
3.6
3.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
26
181
1.41
0.90
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
941
8786
1.06
0.90
3.2
3.2
kpa
4.5
4.5
0.20
900
8447
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
75
607
1.22
0.90
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
75
607
1.22
0.90
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
52
404
1.27
0.89
2.7
2.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
11
62
1.74
0.89
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
62
492
1.24
0.89
1.6
1.5
u/l
5.6
6.3
0.59
51
405
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
75
608
1.21
0.89
1.1
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
14
85
1.62
0.89
2.6
2.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
26
182
1.40
0.88
1.1
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
39
292
1.31
0.88
1.4
1.4
pmol/l
15.4
16.8
0.63
30
238
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
65
521
1.23
0.86
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
65
521
1.23
0.86
1.3
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
86
1.60
0.85
2.9
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
137
1176
1.15
0.84
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
117
993
1.16
0.84
2.2
2.3
u/field
2.4
2.2
0.10
47
361
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
225
1993
1.11
0.83
1.3
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1140
10724
1.05
0.83
4.0
3.8
mmol/l
1.8
1.9
0.60
933
8697
(3024471) HLA-A [Type]
28
201
1.37
0.83
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
30
218
1.35
0.83
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
74
604
1.21
0.83
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
110
0.54
0.83
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
89
740
1.18
0.82
1.3
1.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
31
227
1.34
0.82
1.1
1.2
pmol/l
309.3
310.7
0.01
21
161
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
113
0.52
0.82
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
74
605
1.20
0.82
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
74
605
1.20
0.82
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
296
3174
0.91
0.81
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
127
1088
1.15
0.81
1.1
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
27
194
1.37
0.80
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
21
144
1.43
0.80
3.0
3.3
u/field
0.4
0.5
0.18
21
144
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
112
1.49
0.79
1.3
1.6
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
8
47
1.67
0.79
4.8
3.5
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
25
0.00
0.79
0.0
1.2
—
1.8
—
0
20
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
36
272
1.30
0.78
1.1
1.1
miu/ml
1775.1
1637.9
0.31
36
272
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
24
170
1.39
0.78
11.8
12.2
mmol/l
4.5
5.5
2.23
24
170
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
44
342
1.27
0.78
2.0
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
261
2341
1.10
0.78
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
160
0.61
0.77
1.6
1.5
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
12
73
1.62
0.77
1.2
1.3
ml/s/173m2
1.7
0.8
—
7
44
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
488
4495
1.07
0.76
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
248
1.31
0.75
1.1
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
19
263
0.71
0.75
1.6
1.3
g/l
22.5
49.4
0.63
13
205
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
38
474
0.79
0.75
1.5
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
11
66
1.64
0.74
4.6
4.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
24
172
1.37
0.74
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
114
978
1.15
0.73
1.5
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
56
452
1.22
0.73
1.1
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1074
10132
1.05
0.72
2.2
2.4
ug/l
6.3
7.0
0.52
872
8620
(44806420)
26
339
0.75
0.72
2.3
2.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
107
1.47
0.71
7.5
4.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
75
625
1.18
0.70
1.1
1.2
titre
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
92
780
1.16
0.70
1.6
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
248
2233
1.09
0.70
1.6
1.7
mg/l
3.3
3.6
0.18
176
1609
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
91
1.51
0.70
1.0
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
40
1.72
0.70
1.6
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
57
1.55
0.69
1.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
41
322
1.25
0.69
1.1
1.1
u/ml
2.0
8.3
—
5
27
(3030313) Adrenal Ab [Titer] in Serum
7
41
1.68
0.68
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
106
911
1.14
0.68
1.5
1.6
—
—
—
0
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
5
27
1.82
0.67
11.4
5.8
g/l
2.0
1.5
—
5
27
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
5
27
1.82
0.67
1.0
1.0
u/ml
0.0
6.1
—
5
21
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
79
665
1.17
0.67
1.5
1.6
u/l
9.5
6.1
0.62
33
328
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
90
0.55
0.67
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
107
923
1.14
0.66
2.6
2.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
37
289
1.26
0.66
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
149
1313
1.12
0.66
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
45
360
1.23
0.65
1.8
1.6
nmol/l
2.0
5.5
1.93
33
304
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
5
28
1.76
0.65
7.6
4.9
umol/l
392.0
398.3
—
5
28
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
14
93
1.48
0.64
1.1
1.2
umol/24h
1.7
1.6
0.17
14
93
(4198724)
27
203
1.31
0.64
2.0
1.6
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
44
1.56
0.63
1.4
2.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
105
1170
0.88
0.63
1.1
1.1
iu/ml
21.3
9465.1
0.56
18
256
(3027273) Bicarbonate [Moles/volume] in Venous blood
582
5434
1.06
0.62
3.7
3.5
mmol/l
25.1
25.2
0.23
550
5278
(3047189) Immunofixation for 24 hour Urine
67
561
1.17
0.62
1.5
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
29
363
0.78
0.62
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
54
632
0.84
0.62
1.5
1.5
—
—
—
0
0
(3036603) Volume of Urine
77
653
1.16
0.61
1.4
1.6
ml
1983.6
1907.2
0.11
17
162
(4024509)
112
976
1.13
0.61
1.8
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
111
1.42
0.61
1.8
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
44
355
1.22
0.60
1.4
1.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
19
0.00
0.60
0.0
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
19
0.00
0.60
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
30
1.64
0.60
3.8
16.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
53
437
1.19
0.59
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
206
1.29
0.59
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
22
163
1.33
0.58
1.8
1.7
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
23
0.00
0.58
0.0
1.2
—
2.6
—
0
23
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
12807.3
—
0
8
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
23
172
1.31
0.57
9.1
4.7
u/l
33.2
68.7
0.92
13
58
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
121
1.38
0.57
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
24
181
1.30
0.57
1.2
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
29
225
1.27
0.56
1.5
1.4
ug/l
0.4
0.4
0.11
13
130
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
13
88
1.45
0.56
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
85
0.58
0.56
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
18
130
1.36
0.56
1.2
1.3
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
6
36
1.64
0.56
1.7
1.2
umol/l
17.3
17.2
—
6
28
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
388
4041
0.94
0.56
3.4
3.2
u/ml
1912.6
2378.4
0.09
345
3431
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
537
5024
1.05
0.55
3.9
4.2
%
49.4
47.0
1.45
530
4965
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
46
377
1.20
0.55
1.6
1.5
ug/l
2.4
5.3
1.24
36
297
(3008757) Leukocyte morphology finding [Identifier] in Blood
125
1105
1.11
0.55
4.7
3.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
124
1096
1.11
0.55
1.6
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
37
1.59
0.54
1.8
9.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
24
183
1.29
0.53
1.8
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
30
236
1.25
0.53
1.2
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
9
61
1.45
0.53
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
22
278
0.78
0.52
1.2
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
160
1718
0.91
0.52
2.4
1.6
nmol/l
1.0
0.8
0.60
131
1427
(3037556) Urate [Mass/volume] in Serum or Plasma
37
299
1.22
0.52
1.3
1.5
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
28
219
1.26
0.52
2.3
1.8
mmol/l
1.2
1.2
0.12
28
209
(40768806) Pleura Pathology biopsy report
167
1505
1.09
0.52
1.6
1.6
—
—
—
0
0
(3001729) Color of Synovial fluid
6
99
0.60
0.51
1.3
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
63
1.40
0.51
1.1
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
112
990
1.11
0.51
1.2
1.1
u/ml
1.1
1.4
0.29
47
375
(3014599) Egg white IgE Ab [Units/volume] in Serum
35
282
1.22
0.51
1.0
1.1
u/ml
0.6
1.4
1.03
11
73
(40757373) Influenza virus identified in Isolate
32
256
1.23
0.50
1.7
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
96
843
1.12
0.49
1.1
1.1
u/ml
0.9
1.1
0.13
31
338
(3003888) Timothy IgE Ab [Units/volume] in Serum
99
871
1.12
0.49
1.1
1.1
u/ml
4.9
4.4
0.09
41
407
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
95
834
1.12
0.49
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
95
834
1.12
0.49
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
95
834
1.12
0.49
1.6
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
109
965
1.11
0.49
1.8
1.9
g/24h
1.3
1.1
—
6
39
(40768795) Lymph node Pathology biopsy report
109
965
1.11
0.49
1.2
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
13
91
1.40
0.49
1.7
2.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
20
151
1.30
0.49
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
50
573
0.86
0.48
1.8
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
65
729
0.88
0.47
1.4
1.5
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
20
152
1.29
0.47
2.2
2.3
—
85.3
—
0
23
(3006270) Folate [Moles/volume] in Blood
108
959
1.11
0.47
1.3
1.2
nmol/l
289.4
337.2
2.09
94
753
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
83
726
1.12
0.46
1.1
1.2
titre
84.3
159.3
1.75
14
149
(3022493) Free Hemoglobin [Mass/volume] in Plasma
52
440
1.16
0.46
7.3
3.4
mg/l
65.5
598.4
0.50
30
314
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
100
885
1.11
0.46
1.1
1.1
u/ml
3.0
4.0
0.43
28
330
(3044941) Cell count panel - Synovial fluid
180
1639
1.08
0.46
1.4
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
115
0.68
0.45
1.6
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
117
1046
1.10
0.45
1.2
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
127
1.32
0.45
1.1
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
36
296
1.20
0.45
1.1
1.7
u/ml
300.0
54145.3
—
5
41
(3001019) Free T4 and TSH panel - Serum or Plasma
272
2520
1.06
0.43
1.6
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
29
234
1.22
0.43
3.0
2.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
137
1238
1.09
0.43
2.6
2.5
u/ml
698.0
627.2
0.05
132
1203
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
53
453
1.15
0.43
1.5
1.4
pmol/l
93.8
137.5
0.26
21
131
(3034092) Cytoplasmic Ig cells/100 cells in Blood
15
111
1.33
0.42
11.4
12.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
91
807
1.11
0.42
1.1
1.1
%
91.6
93.8
0.39
82
742
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
16
120
1.31
0.42
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
68
593
1.13
0.41
1.0
1.0
u/ml
7.6
3.3
0.69
29
237
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
17
0.00
0.40
0.0
1.2
—
3132.2
—
0
17
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
59
1.33
0.40
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
34
1.45
0.39
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
201
1.22
0.39
1.4
1.5
ng/l
102.2
134.9
0.76
25
201
(3020491) Glucose [Moles/volume] in Blood
66
727
0.89
0.39
1.8
2.2
mmol/l
7.0
7.1
0.17
44
512
(40758047) Lysozyme [Mass/volume] in Pleural fluid
18
139
1.27
0.39
1.1
1.3
mg/l
13.1
8.4
0.94
18
130
(3006442) Creatine [Moles/volume] in Serum or Plasma
66
578
1.12
0.39
1.4
1.7
umol/l
59.3
72.5
—
6
32
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
162
1484
1.07
0.38
1.3
1.3
miu/ml
219.4
215.0
0.05
55
568
(3029075) Extractable nuclear Ab panel - Serum
28
229
1.20
0.38
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
141
1286
1.08
0.37
2.2
2.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
73
645
1.11
0.37
1.0
1.0
u/ml
4.9
3.6
0.27
35
250
(3004959) Base excess in Arterial cord blood by calculation
5
36
1.37
0.37
1.0
1.0
—
-3.3
—
0
8
(3006598) pH of Arterial cord blood
5
36
1.37
0.37
1.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
67
1.32
0.37
1.1
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
68
1.30
0.37
1.4
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
27
221
1.20
0.37
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
36
303
1.17
0.37
2.1
1.9
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
15
114
1.29
0.37
2.1
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
60
525
1.12
0.36
2.2
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
12
88
1.34
0.36
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
88
1.34
0.36
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
123
1.28
0.36
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
150
1.25
0.35
1.2
1.2
%
59.2
77.6
—
5
45
(37021550) Renin [Units/volume] in Plasma --upright
25
204
1.20
0.35
1.4
1.3
mu/l
143.8
85.4
0.25
16
156
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
40
341
1.15
0.35
1.1
1.9
%
177.0
160.7
0.60
34
321
(40765096) Chromosome analysis panel by Banding
33
277
1.17
0.35
1.2
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
120
0.74
0.35
1.8
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
119
1083
1.08
0.34
2.4
2.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
63
557
1.11
0.33
1.0
1.0
mg/l
295.4
292.8
0.11
54
501
(3020393) Adenovirus Ag [Presence] in Stool
15
116
1.27
0.33
1.2
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
15
116
1.27
0.33
1.1
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
45
1.31
0.33
1.7
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
100
906
1.09
0.33
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
235
2195
1.05
0.32
1.3
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
90
1.31
0.32
1.3
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
6
46
1.28
0.32
1.0
1.1
—
3.9
—
0
14
(3025130) Human papilloma virus identified in Specimen
70
757
0.91
0.32
1.3
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
27
225
1.18
0.32
2.4
2.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
114
1041
1.08
0.31
3.6
3.5
%
59.5
58.2
0.22
76
625
(3044007) Cell count panel - Peritoneal fluid
28
321
0.86
0.31
1.9
1.9
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
17
135
1.24
0.31
6.6
2.9
ng/l
146.3
168.3
—
7
47
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
54
1.27
0.30
1.3
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
182
0.81
0.29
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
52
460
1.11
0.28
1.3
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
170
0.81
0.28
1.3
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
26
219
1.17
0.28
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
287
2709
1.04
0.27
1.1
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
81
735
1.08
0.27
2.0
1.9
ug/l
2.1
2.3
0.28
68
607
(3007916) DNA double strand Ab [Titer] in Serum
9
116
0.76
0.27
1.1
1.1
—
80.6
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
155
1441
1.06
0.27
1.2
1.2
—
—
—
0
0
(3025315) Body weight
11
84
1.29
0.27
4.9
5.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
126
0.78
0.27
1.8
2.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
15
120
1.23
0.26
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
284
2685
1.04
0.26
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
71
643
1.09
0.26
3.2
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
70
634
1.09
0.25
1.6
2.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
76
1.29
0.25
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
149
1389
1.05
0.25
2.1
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
153
1583
0.95
0.25
1.5
1.5
e6/l
104285.0
50124.4
0.79
88
921
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
26
222
1.15
0.25
1.2
1.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
75
1.18
0.24
1.2
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
287
2720
1.04
0.24
1.2
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
81
0.73
0.24
1.5
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
30
260
1.13
0.24
1.2
1.1
—
—
—
0
0
(44806071)
6
84
0.70
0.23
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
148
1383
1.05
0.23
2.1
1.9
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
23
196
1.15
0.23
2.0
2.9
ml/dl
14.7
14.7
0.00
18
182
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
63
669
0.93
0.22
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
63
668
0.93
0.22
1.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
149
1396
1.05
0.22
2.1
2.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
41
1.20
0.21
1.8
1.5
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
10
0.00
0.21
0.0
7.1
—
6.2
—
0
10
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
63
667
0.93
0.21
1.4
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
188
1.15
0.21
1.3
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
133
1244
1.05
0.21
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
114
1062
1.06
0.21
1.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
17
195
0.86
0.21
2.1
2.1
ug/l
2.8
3.6
—
9
65
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
24
207
1.14
0.21
1.9
1.6
ug/l
8.7
9.4
0.39
24
207
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
13
153
0.83
0.21
1.1
1.2
ug/l
112.4
119.2
—
5
98
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
63
666
0.93
0.21
1.4
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
15
124
1.19
0.20
3.7
2.4
pmol/l
64.0
87.4
0.57
15
111
(40758292) HTLV I+II Ab panel - Serum
14
115
1.20
0.20
1.4
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
47
1.25
0.20
1.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
25
277
0.89
0.20
1.8
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
24
208
1.13
0.20
1.3
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
49
1.20
0.19
1.7
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
79
1.24
0.19
1.9
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
23
199
1.14
0.19
1.4
1.7
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
120
0.82
0.19
1.4
1.8
umol/l
60.1
42.6
—
10
120
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
218
1.13
0.19
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
43
388
1.09
0.18
1.8
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
160
1511
1.04
0.18
1.5
1.5
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
16
135
1.16
0.18
1.1
1.4
—
13.6
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
57
1.21
0.18
1.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
58
1.19
0.18
1.1
1.2
—
—
—
0
0
(4212803)
11
129
0.84
0.17
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
33
355
0.91
0.17
1.7
1.8
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
81
754
1.06
0.16
2.0
1.9
ug/l
3.0
3.8
0.92
74
657
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
70
1.12
0.16
2.1
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
70
1.12
0.16
4.3
5.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
27
240
1.11
0.16
6.6
8.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
61
637
0.94
0.16
1.1
1.0
ng/l
40.6
45.7
0.57
44
415
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
132
1349
0.96
0.16
1.6
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
61
636
0.94
0.15
1.0
1.0
ng/l
303.6
339.0
0.64
44
425
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
38
345
1.08
0.15
2.3
2.6
—
33.8
—
0
10
(3010726) Horse dander IgE Ab [Units/volume] in Serum
80
747
1.05
0.15
1.1
1.1
u/ml
3.3
2.0
0.25
25
183
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
128
1.15
0.15
1.1
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
58
537
1.06
0.14
2.7
2.4
umol/l
22.9
35.5
—
10
56
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
61
634
0.95
0.14
1.0
1.0
ng/l
689.9
687.4
0.01
40
410
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
223
1.10
0.14
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
123
1254
0.96
0.14
4.1
3.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
31
281
1.08
0.13
1.2
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
42
386
1.07
0.13
1.8
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
42
386
1.07
0.13
1.8
1.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
147
1490
0.97
0.12
1.8
1.9
ug/l
17.5
23.7
2.81
138
1448
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
12
102
1.16
0.12
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
143
1362
1.03
0.12
2.2
1.9
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
37
389
0.93
0.12
1.7
1.9
e6/l
662.1
2310.6
0.67
26
265
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
14
155
0.89
0.11
6.7
7.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
130
1240
1.03
0.11
4.3
4.3
umol/l
331.7
341.3
0.27
106
1031
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
113
0.87
0.10
1.4
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
113
0.87
0.10
1.4
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
113
0.87
0.10
1.4
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
33
346
0.94
0.10
1.5
1.7
e6/l
9760.9
13794.2
0.21
18
193
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
19
170
1.10
0.10
2.9
2.8
mg/l
9.2
7.4
0.69
14
135
(3050129) First trimester maternal screen panel - Serum or Plasma
81
826
0.96
0.10
1.5
1.4
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
10
85
1.16
0.10
2.8
1.8
mmol/l
0.5
0.8
—
5
52
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
43
1.14
0.10
1.0
1.2
umol/24h
239.4
330.9
—
5
43
(3039443) Prostate specific Ag panel - Serum or Plasma
136
1302
1.03
0.09
1.6
1.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
23
244
0.93
0.09
1.2
1.5
mmol/l
9.1
8.3
0.47
14
140
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
52
488
1.05
0.09
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
45
421
1.05
0.09
1.1
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
6
55
1.07
0.08
1.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
56
1.05
0.08
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
57
1.03
0.08
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
220
1.07
0.08
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
24
220
1.07
0.08
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
376
3648
1.01
0.08
1.3
1.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
27
249
1.07
0.08
2.6
2.4
mmol/l
6.7
7.8
1.98
18
168
(3038071) Oxygen [Partial pressure] in Mixed venous blood
22
202
1.07
0.07
6.6
8.8
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
82
1.08
0.07
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
160
0.92
0.06
1.4
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
24
222
1.06
0.06
2.0
1.7
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
70
668
1.03
0.06
1.1
1.2
u/l
82.4
100.5
0.98
62
569
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
9
102
0.87
0.06
4.0
5.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
103
0.86
0.06
2.1
2.0
umol/l
16.1
17.4
—
9
103
(3051651) Icteric interference index of Serum or Plasma
73
698
1.03
0.06
4.7
3.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
71
679
1.03
0.06
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
53
504
1.03
0.06
5.6
3.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
60
574
1.03
0.05
1.5
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
18
166
1.07
0.05
1.2
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
205
1.05
0.04
1.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
53
535
0.97
0.04
1.0
1.0
u/ml
2.7
0.3
0.93
15
138
(3020650) Glucose [Presence] in Urine
21
217
0.95
0.04
1.5
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
25
235
1.05
0.04
1.0
1.1
u/ml
0.1
2.5
—
8
36
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
167
0.94
0.04
1.1
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
65
652
0.98
0.03
1.1
1.2
u/l
25.4
27.8
0.15
54
542
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
13
119
1.07
0.03
1.3
1.1
%
20.8
52.6
—
6
53
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
480
1.02
0.03
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
30
285
1.03
0.03
1.4
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
110
1.07
0.03
1.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
18
185
0.96
0.02
1.5
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
53
511
1.02
0.02
1.7
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
53
511
1.02
0.02
1.7
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
53
511
1.02
0.02
1.7
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
53
511
1.02
0.02
1.6
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1253
12337
1.00
0.02
7.6
8.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
53
530
0.98
0.02
2.3
2.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
83
822
0.99
0.00
1.2
1.1
—
—
—
0
0
(4133840)
20
191
1.03
0.00
1.4
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
84
820
1.01
0.00
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
32
310
1.01
0.00
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
174
1715
1.00
0.00
1.5
1.5
e6/l
1982.8
2519.5
0.47
135
1204
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
43
425
0.99
0.00
1.3
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
24
239
0.99
0.00
1.6
2.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
136
1336
1.00
0.00
1.6
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
24
237
1.00
0.00
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
158
1549
1.00
0.00
1.5
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
40
392
1.00
0.00
2.0
2.2
umol/l
55.7
57.2
0.09
26
304
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
46
447
1.01
0.00
1.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
28
271
1.02
0.00
1.0
1.2
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
58
1.02
0.00
1.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
132.4
—
0
8
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
63
0.94
0.00
1.2
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
62
0.95
0.00
1.2
1.1
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
54
0.91
0.00
1.2
1.1
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
97
0.91
0.00
2.3
1.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
61
0.97
0.00
1.2
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
51
0.96
0.00
1.0
1.0
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
79
1.00
0.00
1.3
1.1
u/l
12.6
13.0
—
8
79

Mortality – FinRegistry

Association

Association between endpoint H8_OTHHEARINGLOSS and mortality.

Females

Parameter HR [95% CI] p-value
H8_OTHHEARINGLOSS 0.949 [0.87, 1.03] 0.222
Birth year 1.0 [0.99, 1.01] 0.924

During the follow-up period (1.1.1998 — 31.12.2019), 21397 out of 54019 females with H8_OTHHEARINGLOSS died.

Males

Parameter HR [95% CI] p-value
H8_OTHHEARINGLOSS 0.956 [0.87, 1.05] 0.37
Birth year 0.986 [0.98, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 16050 out of 41752 males with H8_OTHHEARINGLOSS died.

Mortality risk

Mortality risk for people of age

years, who have H8_OTHHEARINGLOSS.

N-year risk Females Males
1 0.09% 0.231%
5 0.529% 1.13%
10 1.385% 2.683%
15 2.951% 5.064%
20 5.432% 8.299%

Relationships between endpoints

Index endpoint: H8_OTHHEARINGLOSS – Other hearing loss

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data